: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Inflammatory Bowel Diseases

Free Subscription

Articles published in Inflamm Bowel Dis
Retrieve available abstracts of 756 articles:
HTML format

Single Articles

September 2025

FUCHTBAUER JD, Brovkina O, Sivickis K, Aalykke C, et al
Gut Mycobiome in Inflammatory Bowel Disease: A Systematic Review of Case-Control Studies.
Inflamm Bowel Dis. 2025 Sep 24:izaf217. doi: 10.1093.
PubMed Abstract available

TEIGEN L
Deciphering Mechanisms Underlying Success of Microbiome-Targeted Diet Therapy in Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Sep 23:izaf203. doi: 10.1093.
PubMed

INNOCENTI T, Rocco C, Scarallo L, Lionetti P, et al
Systematic Review of Available Intestinal Ultrasound Scores for Inflammatory Bowel Disease and Update on Validation Studies.
Inflamm Bowel Dis. 2025 Sep 20:izaf183. doi: 10.1093.
PubMed Abstract available

SINOPOULOU V, Gordon M, Liu S, Albuquerque DAN, et al
Immunomodulators and Advanced Therapies for Induction of Remission in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Inflamm Bowel Dis. 2025 Sep 19:izaf191. doi: 10.1093.
PubMed Abstract available

TAN EX, An V, Garg M
Diverting Loop Ileostomy as an Alternative to Emergent Colectomy in Acute Severe Ulcerative Colitis Flare following Checkpoint-Inhibitor Therapy.
Inflamm Bowel Dis. 2025 Sep 19:izaf187. doi: 10.1093.
PubMed

DRUGG HAHN G, Lakatos PL, Maedler-Kron C, Marcus V, et al
Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Sep 19:izaf008. doi: 10.1093.
PubMed Abstract available

OH SH, Rajendra C
Capsule Endoscopy in Very Early-Onset Inflammatory Bowel Disease: Supporting the Clinician's Role in Disease Interpretation.
Inflamm Bowel Dis. 2025 Sep 18:izaf165. doi: 10.1093.
PubMed

SHEHAB M, Alrashed O, Alrashed F, Alyousefi R, et al
Comparative Efficacy of Medical Therapies in Reducing the Risk of Postoperative Recurrence in Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Inflamm Bowel Dis. 2025 Sep 18:izaf186. doi: 10.1093.
PubMed Abstract available

BAEKGAARD FRW, Kjaer MD, Moller S, Hovvang SW, et al
The Severity of Rectal Inflammation and Pouch Surgery Outcome in Patients with Ulcerative Colitis: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2025 Sep 16:izaf194. doi: 10.1093.
PubMed Abstract available

SCHREIBER S, Lee SD, van der Woude CJ, Marin-Jimenez I, et al
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Inflamm Bowel Dis. 2025 Sep 15:izaf163. doi: 10.1093.
PubMed Abstract available

CHEN Q, McNinch C, May E, LaPoint P, et al
Distinct Retrotransposon Transcriptome in Pediatric Crohn's Disease.
Inflamm Bowel Dis. 2025 Sep 15:izaf190. doi: 10.1093.
PubMed Abstract available

FROST S, Ambastha C, Patel D, Roney A, et al
Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort Study.
Inflamm Bowel Dis. 2025 Sep 15:izaf170. doi: 10.1093.
PubMed Abstract available

JAIRATH V, Adsul S, Allocca M, Danese S, et al
Integrating Intestinal Ultrasound to Clinical Trials in Patients With Crohn's Disease: Opportunities and Challenges.
Inflamm Bowel Dis. 2025 Sep 15:izaf196. doi: 10.1093.
PubMed Abstract available

VERMEER E, Prins FM, Hidding IJ, Jagt JZ, et al
Metagenomic Sequencing Reveals Distinct Gut Microbiome Profiles in Therapy-Naive de Novo Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Sep 12:izaf184. doi: 10.1093.
PubMed Abstract available

BOHAR B, Thomas JP, Liu Y, Brooks-Warburton J, et al
Patient-Specific Regulatory Network Rewiring in Inflammatory Bowel Disease: How Genetic Polymorphisms Divert Incoming Signals and Contribute to Disease Pathogenesis.
Inflamm Bowel Dis. 2025 Sep 7:izaf173. doi: 10.1093.
PubMed Abstract available

D'ARCANGELO G, De Mitri D, Busato L, Bottino L, et al
The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn's Disease.
Inflamm Bowel Dis. 2025 Sep 5:izaf193. doi: 10.1093.
PubMed Abstract available

KLEIN S, Sivasailam B, Alizadeh M, Malter L, et al
Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City.
Inflamm Bowel Dis. 2025 Sep 5:izaf174. doi: 10.1093.
PubMed Abstract available

Correction to: Fecal Microbial Community Profiling Allows Discrimination of Phenotype and Treatment Response in Pediatric Crohn's Disease and Ulcerative Colitis-An International Meta-Analysis.
Inflamm Bowel Dis. 2025 Sep 4:izaf200. doi: 10.1093.
PubMed

DAY AS, Slater R, Young RB, Wheeler RZ, et al
Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Sep 3:izaf177. doi: 10.1093.
PubMed Abstract available

AKASH H, Pandis N, Manschiebel W, Burisch J, et al
A Systematic Review and Meta-Analysis of Animal Models on the Possible Link Between Periodontitis and Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2025;31:2561-2583.
PubMed Abstract available

STENKE E, Alhassan D, Moclair M, Cooper S, et al
Higher-Dose Infliximab Induction Achieves Better Maintenance Trough Levels in a National Pediatric IBD Cohort-A Retrospective Study.
Inflamm Bowel Dis. 2025;31:2331-2337.
PubMed Abstract available

August 2025

TAL N, Baram L, Gehlhaar A, Gu W, et al
RELA Haploinsufficiency Manifesting as an Atypical Phenotype of Crohn's Disease.
Inflamm Bowel Dis. 2025 Aug 28:izaf159. doi: 10.1093.
PubMed Abstract available

MAHADEVAN U, Seow CH, Barnes EL, Chaparro M, et al
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Aug 28:izaf171. doi: 10.1093.
PubMed Abstract available

DEISSOVA T, Al Tukmachi D, Radova L, Bohosova J, et al
Tissue MicroRNA Expression Signatures as Diagnostic Biomarkers and Predictors of Residual Disease Activity and Relapse in Treatment-Naive Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Aug 26:izaf120. doi: 10.1093.
PubMed Abstract available

GEEGANAGE G, Gade A, Saraga A, Deyhim T, et al
Long-term Outcomes of Patients with Crohn's Disease Treated with Risankizumab.
Inflamm Bowel Dis. 2025 Aug 26:izaf162. doi: 10.1093.
PubMed Abstract available

LERCHOVA T, Ludvigsson J, Marild S, Imberg H, et al
Early-Life Body Mass Index and Inflammatory Bowel Disease Risk: A Scandinavian Birth Cohort Study.
Inflamm Bowel Dis. 2025 Aug 25:izaf167. doi: 10.1093.
PubMed Abstract available

Correction to: A Role for Leucine-Rich alpha2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Aug 25:izaf198. doi: 10.1093.
PubMed

EREN DURMUS M, Koker G
Comment on "Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2025 Aug 23:izaf192. doi: 10.1093.
PubMed

ZHOU R, Bai X, Zhang D, Zhu Y, et al
Role of lncRNA MGP202 in Modulating B Cell Dynamics and Its Implications in Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Aug 23:izaf176. doi: 10.1093.
PubMed Abstract available

MAR JS, Nguyen A, Scherl A, Wittke M, et al
InflammationBacterial Dysbiosis Observed in the Terminal Ileum of Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Aug 22:izaf160. doi: 10.1093.
PubMed

BOYD T, Friedman S, Newman KL, Chedid V, et al
Sexual Health Concerns and Health Care Experiences of LGBTQ+ Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Aug 21:izaf158. doi: 10.1093.
PubMed Abstract available

SWAMINATHAN A, Hou D, Borichevsky GM, Kettle AJ, et al
Author's Response to Comment on "Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2025 Aug 21:izaf189. doi: 10.1093.
PubMed

NOVIELLO D, Atreya R, Noor NM
Resolving Loss of Response to Ustekinumab in Crohn's Disease: POWER Through or Switch Treatment?
Inflamm Bowel Dis. 2025 Aug 20:izaf179. doi: 10.1093.
PubMed

BAKER NM, Soltero KS, Ebriani J, Dalal RS, et al
Clinical Characteristics and Treatment Patterns in a Large Cohort of Patients with Metastatic Crohn's Disease.
Inflamm Bowel Dis. 2025 Aug 20:izaf164. doi: 10.1093.
PubMed

YERUSHALMY-FELER A, Spencer EA, Bergstein S, Mitrova K, et al
Real-World Experience with Upadacitinib for Pediatric Acute Severe Ulcerative Colitis: An International Multicenter Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN.
Inflamm Bowel Dis. 2025 Aug 20:izaf166. doi: 10.1093.
PubMed Abstract available

LEE SH, Lopes E, Colombel JF, Ungaro R, et al
Identifying Potential Targets for the Interception of Inflammatory Bowel Disease: Toward Precision Prevention.
Inflamm Bowel Dis. 2025 Aug 20:izaf168. doi: 10.1093.
PubMed Abstract available

KUANG X, Jia X, Peng X, Zheng X, et al
Ulcerative Colitis Aggravates Periodontitis via Inducing Myelopoiesis.
Inflamm Bowel Dis. 2025 Aug 12:izaf150. doi: 10.1093.
PubMed Abstract available

LUSHNIKOVA A, Wickbom A, Bohr J, Kruse R, et al
Increased Colonic Levels of CD8+ Cytotoxic T lymphocyte-Associated Mediators in Patients With Microscopic Colitis.
Inflamm Bowel Dis. 2025;31:2231-2243.
PubMed Abstract available

JIANG M, Jia Y, Ma C, Zeng Z, et al
Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway.
Inflamm Bowel Dis. 2025;31:2217-2230.
PubMed Abstract available

LEWIN S, Long M, Cohen R, Scherl E, et al
Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry.
Inflamm Bowel Dis. 2025;31:2106-2111.
PubMed Abstract available

BOUWKNEGT DG, van der Weide AHC, Dijkstra G, Goetgebuer RL, et al
Pregnancy With a Stoma is Feasible, Though Associated With Manageable Complications.
Inflamm Bowel Dis. 2025;31:2195-2203.
PubMed Abstract available

YARUR AJ, Chiorean MV, Allegretti JR, Cross RK, et al
Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program.
Inflamm Bowel Dis. 2025;31:2144-2153.
PubMed Abstract available

July 2025

PARK S, Keyashian K, Ho A, Limsui D, et al
Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn's Disease of the Pouch.
Inflamm Bowel Dis. 2025 Jul 25:izaf146. doi: 10.1093.
PubMed Abstract available

YE S, Yang X, Chen X
Comment On: Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN.
Inflamm Bowel Dis. 2025 Jul 21:izaf069. doi: 10.1093.
PubMed

MA J, Feng W, Zhou N
Breaking Conventions: Innovative Reflections on the Medication Use Research of Inflammatory Bowel Disease in Adults and the Elderly.
Inflamm Bowel Dis. 2025 Jul 21:izaf056. doi: 10.1093.
PubMed

BAK MTJ, Olivera PA, Hernandez-Rocha C, Borowski K, et al
Isolated Anastomotic Ulcers Are Associated with a Higher Long-Term Risk for Postoperative Recurrence and a Differential Mucosa-Associated Microbiome Composition in Patients with Crohn's Disease Following Ileocolic Resection.
Inflamm Bowel Dis. 2025 Jul 16:izaf147. doi: 10.1093.
PubMed Abstract available

KITAHATA S, Saito M, Kimura Y, Nakamura A, et al
Mirikizumab Efficacy in Ulcerative Colitis: Association With Pretreatment Geboes Score Features in a Case Series.
Inflamm Bowel Dis. 2025 Jul 16:izaf152. doi: 10.1093.
PubMed

DAI C, Huang YH
The Association of Inflammatory Bowel Disease and Eosinophilic Esophagitis: True Link or Surveillance Artifact?
Inflamm Bowel Dis. 2025 Jul 12:izaf151. doi: 10.1093.
PubMed

OLDENBURG L, Hens B, Hollenberg M, D'Haens G, et al
Endoscopic Recurrence in Crohn's Disease Patients With Long-Term Ileostomy.
Inflamm Bowel Dis. 2025 Jul 12:izaf153. doi: 10.1093.
PubMed Abstract available

HAGIWARA SI, Shimizu H, Nambu R, Jimbo K, et al
Feasibility and Safety of Small Bowel Capsule Endoscopy in Very Early-Onset Inflammatory Bowel Disease: A Multi-Institutional Study.
Inflamm Bowel Dis. 2025 Jul 8:izaf144. doi: 10.1093.
PubMed Abstract available

GREYWOODE R, Philippou A, Ullman T, Keefer L, et al
Culturally Informed Digital Behavioral Intervention Development for Inflammatory Bowel Disease: A Qualitative Study.
Inflamm Bowel Dis. 2025 Jul 8:izaf145. doi: 10.1093.
PubMed Abstract available

YANOFSKY R, Tandon P
Response to "The Association of Inflammatory Bowel Disease and Eosinophilic Esophagitis: True Link or Surveillance Artifact?
Inflamm Bowel Dis. 2025 Jul 8:izaf149. doi: 10.1093.
PubMed

BLESL A, Binder L, Halwachs B, Baumann-Durchschein F, et al
The Fecal Microbiome of IBD Patients Is Less Divertible by Bowel Preparation Compared to Healthy Controls: Results From a Prospective Study.
Inflamm Bowel Dis. 2025;31:2007-2018.
PubMed Abstract available

LAURETI S, Cappelli A, Isopi C, Gentilini L, et al
Autologous Microfragmented Adipose Tissue Injection in Refractory Complex Crohn's Perianal Fistulas: Long-Term Results at 6.7 Years Mean Follow-up.
Inflamm Bowel Dis. 2025;31:1943-1951.
PubMed Abstract available

CENTORRINO E, Ferrari D, Harmsen WS, Larson DW, et al
Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing?
Inflamm Bowel Dis. 2025;31:1952-1960.
PubMed Abstract available

MIYAZAWA A, Nambu R, Shimizu H, Kudo T, et al
Long-Term Course and Prognostic Factors in Pediatric Ulcerative Proctitis: A Multicenter Cohort Study.
Inflamm Bowel Dis. 2025;31:1902-1909.
PubMed Abstract available

BOCCHINI B, Martinelli M, Strisciuglio C, Stellato P, et al
Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia.
Inflamm Bowel Dis. 2025 Jul 1:izaf139. doi: 10.1093.
PubMed

Correction to: Novel mRNA Signature for Anti-TNF-alpha Therapy Primary Response in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Jul 1:izaf140. doi: 10.1093.
PubMed

PATRICK D, Siddiq L, Boyce A
An Acute Onset Sweet Syndrome After First Vedolizumab Dose in Crohn's Disease.
Inflamm Bowel Dis. 2025 Jul 1:izaf122. doi: 10.1093.
PubMed

June 2025

AHUJA D, Anvari S, Wong ECL, Dulai P, et al
Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial.
Inflamm Bowel Dis. 2025 Jun 30:izaf137. doi: 10.1093.
PubMed Abstract available

TAKEDA T, Nishimata N, Fujioka S, Tsuruoka N, et al
Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn's Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team.
Inflamm Bowel Dis. 2025 Jun 30:izaf138. doi: 10.1093.
PubMed Abstract available

ALDRIAN D, Pollio A, Mayerhofer C, Diederen K, et al
Fecal Microbial Community Profiling Allows Discrimination of Phenweotype and Treatment Response in Pediatric Crohn's Disease and Ulcerative Colitis-An International Meta-Analysis.
Inflamm Bowel Dis. 2025 Jun 28:izaf135. doi: 10.1093.
PubMed Abstract available

FERNANDES SR, Rodrigues IC, Neves ADS, Saraiva S, et al
Early Top-Down Treatment With Biologics Improves the Rates of Transmural Remission in Crohn's Disease-A Risk-Adjusted Propensity Score Matched Analysis.
Inflamm Bowel Dis. 2025 Jun 25:izaf112. doi: 10.1093.
PubMed Abstract available

FUMERY M, Savoye G, Sarter H, Dupont-Lucas C, et al
Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease.
Inflamm Bowel Dis. 2025 Jun 25:izaf133. doi: 10.1093.
PubMed Abstract available

HUANG JL, Tan WT, Liu H
Prostaglandins and Inflammatory Bowel Disease: From Mechanism to Clinic.
Inflamm Bowel Dis. 2025 Jun 25:izaf121. doi: 10.1093.
PubMed Abstract available

SCHREIBER-STAINTHORP W, Faye AS, Axelrad JE
Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Jun 24:izaf130. doi: 10.1093.
PubMed

POWERS JC, Westbrook Cates K, Dester E, Zemanek M, et al
Inflammation of the Rectal Cuff is Associated With Strictures and Fistulas in Patients With Ulcerative Colitis who Have an Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2025 Jun 24:izaf127. doi: 10.1093.
PubMed Abstract available

KOCHHAR GS, Khataniar H, Hashash JG, Regueiro M, et al
Natural History, Treatment Persistence and Predictors of Treatment Failure in Patients With Ulcerative Colitis on 5-Aminosalicylic Acid: A US Population-Level Cohort Study.
Inflamm Bowel Dis. 2025 Jun 24:izaf129. doi: 10.1093.
PubMed Abstract available

MIKHAIL I, Al Ta'ani O, Aburumman R, Alsakarneh S, et al
Patients With Crohn's Disease and Terminal Ileum Resection are at Increased Risk of Colorectal Cancer: A Population-Based Study.
Inflamm Bowel Dis. 2025 Jun 18:izaf118. doi: 10.1093.
PubMed Abstract available

MEIMA M, Westerhout J, Meijerink M, Bijlsma S, et al
Food Compounds Associated With Disease Activity in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Jun 16:izaf126. doi: 10.1093.
PubMed Abstract available

BOURGONJE AR
Dualistic Implications of Angiotensin-Converting Enzyme 2 (ACE2) Expression in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Jun 16:izaf131. doi: 10.1093.
PubMed

WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's Disease.
Inflamm Bowel Dis. 2025 Jun 16:izaf124. doi: 10.1093.
PubMed Abstract available

Correction to: Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients.
Inflamm Bowel Dis. 2025 Jun 16:izaf134. doi: 10.1093.
PubMed

YOGEV D, Weintraub Y, Ledder O, Matar M, et al
Safety and Effectiveness of QingDai (Indigo naturalis) in Children With Mild-to-Moderate Ulcerative Colitis: A Short-Term 6-Week Open-Label Trial.
Inflamm Bowel Dis. 2025 Jun 13:izaf119. doi: 10.1093.
PubMed

RUBIN DT, Hart AL
A Guide to the Patient-Centric Use of Vedolizumab for Crohn's Disease.
Inflamm Bowel Dis. 2025 Jun 13:izaf072. doi: 10.1093.
PubMed Abstract available

PISANI LF, Albertini Petroni G, Crespi G, Mola S, et al
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease.
Inflamm Bowel Dis. 2025;31:1690-1701.
PubMed Abstract available

WHITE I, Karki C, Geransar P, Leisle L, et al
Impact of Seton Use on Clinical, Patient-Reported, and Healthcare Resource Utilization Outcomes in Complex Crohn's Perianal Fistulas: A Systematic Literature Review.
Inflamm Bowel Dis. 2025;31:1556-1566.
PubMed Abstract available

WOOD DW, Treiman K, Rivell A, van Deen WK, et al
Communicating Information Regarding IBD Remission to Patients: Evidence From a Survey of Adult Patients in the United States.
Inflamm Bowel Dis. 2025;31:1605-1615.
PubMed Abstract available

DAVE M, Power S, Herfarth HH, Barnes EL, et al
Assessing the Value of Histology and Anatomic Segment Evaluation Among Patients Undergoing Pouchoscopy.
Inflamm Bowel Dis. 2025;31:1514-1519.
PubMed Abstract available

YANOFSKY R, Jogendran R, Hoxha T, Pathak A, et al
The Association of Inflammatory Bowel Disease and Eosinophilic Esophagitis: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2025 Jun 4:izaf095. doi: 10.1093.
PubMed Abstract available

May 2025

YZET C, Moreau C, Chatelain D, Meudjo E, et al
Rectal and Rectosigmoid Endoscopy to Assess Endoscopic and Histological Remission in Ulcerative Colitis: A Prospective Study.
Inflamm Bowel Dis. 2025 May 24:izaf094. doi: 10.1093.
PubMed Abstract available

HOU D, Swaminathan A, Borichevsky GM, Frampton CM, et al
Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 May 24:izaf110. doi: 10.1093.
PubMed Abstract available

BORICHEVSKY GM, Swaminathan A, Smith BR, Edwards TS, et al
Myeloperoxidase Enzyme Activity in Feces Reflects Endoscopic Severity in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 May 24:izaf109. doi: 10.1093.
PubMed Abstract available

CHOI D, Kellar A, Klein J, Choi NK, et al
Incidence and Risk Factors for Development of Acne (JAKne) in Patients with Inflammatory Bowel Disease Treated With Upadacitinib.
Inflamm Bowel Dis. 2025 May 24:izaf115. doi: 10.1093.
PubMed

BAK MTJ, de Vries AC, Witjes CDM, Arkenbosch JHC, et al
Intraoperative Autologous Platelet-Rich Stroma Injection as Add-On to Fistula Curettage and Closure of the Internal Orifice Demonstrates a Favorable Outcome in Long-Term in Patients Suffering from Therapy-Refractory Perianal Fistulizing Crohn's Diseas
Inflamm Bowel Dis. 2025 May 24:izaf011. doi: 10.1093.
PubMed Abstract available

SUN J, Brooks EC, Houshyar Y, Connor SJ, et al
Unravelling the Relationship Between Obesity and Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 May 21:izaf098. doi: 10.1093.
PubMed Abstract available

ISHIDA N, Tamura S, Takebe T, Takahashi K, et al
Usefulness of Prostaglandin E-Major Urinary Metabolite in Monitoring Crohn's Disease Activity: A Prospective Cross-Sectional Study.
Inflamm Bowel Dis. 2025 May 21:izaf025. doi: 10.1093.
PubMed Abstract available

NISHIDA Y, Hosomi S, Fujimoto K, Kobayashi Y, et al
Lack of Efficacy of Concomitant 5-Aminosalicylic Acid With Vedolizumab in Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
Inflamm Bowel Dis. 2025 May 21:izaf088. doi: 10.1093.
PubMed

AOYAMA K, Yamamura R, Katsurada T, Shimizu T, et al
Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients.
Inflamm Bowel Dis. 2025 May 13:izaf092. doi: 10.1093.
PubMed Abstract available

WANG H, Chen Y, He J, Luo Z, et al
Biological Ageing and the Risk of Inflammatory Bowel Disease: Exploring the Role of Lifestyle and Genetic Susceptibility in a Nationwide Prospective Study.
Inflamm Bowel Dis. 2025 May 13:izaf106. doi: 10.1093.
PubMed Abstract available

STRATIL AS, Friedrich B, Brunner P, Rath S, et al
Six-Year Observation Data Reveal Reduction in Concomitant Steroid Overuse for Inflammatory Bowel Disease in Germany.
Inflamm Bowel Dis. 2025 May 13:izaf108. doi: 10.1093.
PubMed Abstract available

PIROLLI NH, Raufman JP, Jay SM
Therapeutic Potential and Translational Challenges for Bacterial Extracellular Vesicles in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 May 13:izaf107. doi: 10.1093.
PubMed Abstract available

MASSIRONI S, Pigoni A, Vegni EAM, Keefer L, et al
The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis.
Inflamm Bowel Dis. 2025;31:1441-1459.
PubMed Abstract available

SILA S, Aloi M, Cucinotta U, Gianolio L, et al
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD.
Inflamm Bowel Dis. 2025;31:1263-1271.
PubMed Abstract available

PRENTICE RE, Cho SX, Bell SJ, Nold-Petry CA, et al
Innate and Adaptive Immunity is not Impacted by Inflammatory Bowel Disease Medications in Pregnant Women and Their Offspring.
Inflamm Bowel Dis. 2025 May 9:izaf052. doi: 10.1093.
PubMed Abstract available

KOKKOTIS G, Bamias G
Past But Not Forgotten: Innate Factors Affect the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 May 9:izaf105. doi: 10.1093.
PubMed

GOZDZIK M, Unninayar D, Siegal DM, Sarker AK, et al
Risk Factors for Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis by Phase of Care.
Inflamm Bowel Dis. 2025 May 9:izaf078. doi: 10.1093.
PubMed Abstract available

MUNASINGHE S, Chandrakasan S
Maternal Microchimerism, a Red Flag or a Red Herring in Very-Early-Onset Inflammatory Bowel Disease?
Inflamm Bowel Dis. 2025 May 9:izaf070. doi: 10.1093.
PubMed

LOVETT GC, Schulberg JD, Hamilton AL, Wright EK, et al
Crohn's Disease Stricture Response to Treatment Assessed with Magnetic Resonance Imaging and Intestinal Ultrasound: STRIDENT Randomized Trial.
Inflamm Bowel Dis. 2025 May 8:izaf073. doi: 10.1093.
PubMed Abstract available

ALBERT S, Marques P, Algarra A, Blanc E, et al
Monitoring Structural Bowel Damage in Patients With Crohn's Disease Using Intestinal Ultrasonography: Can It Be Reversed by Biological Treatment?
Inflamm Bowel Dis. 2025 May 8:izaf100. doi: 10.1093.
PubMed Abstract available

MCAULIFFE T, Salwen-Deremer JK, Siegel CA
Disparities in Access and Treatment for Rural Patients With Inflammatory Bowel Disease: A Survey of Inflammatory Bowel Disease Patients and Providers.
Inflamm Bowel Dis. 2025 May 8:izaf090. doi: 10.1093.
PubMed Abstract available

FENG Y, Wang S, Li S
Non-Typhoidal Salmonella Infections and Inflammatory Bowel Disease Risk: New Findings and Multidimensional Perspectives for Future Research.
Inflamm Bowel Dis. 2025 May 5:izaf082. doi: 10.1093.
PubMed

PAL P, Mateen MA, Gupta R, Tandan M, et al
Multifaceted Endoscopic Approach (Stricturotomy, Balloon Dilation, Fistulotomy, and Seton Placement) Guided by Intestinal Ultrasound to Avert Surgery in Complicated Crohn's Disease During Lactation.
Inflamm Bowel Dis. 2025 May 2:izaf076. doi: 10.1093.
PubMed

April 2025

ERNEST-SUAREZ K, Noor NM
Not All Transmural Healing is Equal in Crohn's Disease: Magnetic Resonance Enterography and Intestinal Ultrasound for Stricture Assessment in the STRIDENT Trial.
Inflamm Bowel Dis. 2025 Apr 29:izaf093. doi: 10.1093.
PubMed

BARENBOIM A, Maharshak N
Reply: Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2025 Apr 29:izaf091. doi: 10.1093.
PubMed

PLAKOTARIS E, Theriot T, Langley C, Haas C, et al
Diagnosing the Overlap: Metastatic Crohn's Disease With Hidradenitis Suppurativa-Like Features.
Inflamm Bowel Dis. 2025 Apr 29:izaf083. doi: 10.1093.
PubMed

REA K, Robbertz A, Westbrook A, Buzenski J, et al
Biofeedback-Enhanced Cognitive-Behavioral Therapy Delivered Virtually to Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.
Inflamm Bowel Dis. 2025 Apr 29:izaf061. doi: 10.1093.
PubMed Abstract available

DAI C, Huang YH
Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2025 Apr 26:izaf080. doi: 10.1093.
PubMed

RODRIGUEZ A, Quintero MA, Hazime H, Killian R, et al
Risk Factors for Chronic Kidney Disease in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2025 Apr 25:izaf039. doi: 10.1093.
PubMed Abstract available

HANSEN SH, Maseng MG, Granno O, Vestergaard MV, et al
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort.
Inflamm Bowel Dis. 2025 Apr 25:izaf060. doi: 10.1093.
PubMed Abstract available

HUET J, Mathieu K, Dodel M, Coban D, et al
Transmural Healing Assessed by Combination of Fecal Calprotectin and Intestinal Ultrasonography Is Associated With Reduced Risk of Bowel Damage Progression in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2025 Apr 25:izaf068. doi: 10.1093.
PubMed Abstract available

KHALILI H, Forss A, Soderling J, Broms G, et al
Statin Use is Associated with a Less Severe Disease Course In Inflammatory Bowel Disease: A Nationwide Cohort Study 2006-2020.
Inflamm Bowel Dis. 2025 Apr 25:izaf077. doi: 10.1093.
PubMed Abstract available

LIMDI JK
Contraception, Unintended Pregnancy, and Inflammatory Bowel Disease: When (and Why) Failure is Not an Option....
Inflamm Bowel Dis. 2025 Apr 23:izaf081. doi: 10.1093.
PubMed

LENTI MV, Santacroce G, Di Sabatino A
Rethinking the Use of Biologics in Inflammatory Bowel Disease Patients With Malignancy: Insights From the Treatment of Immune Checkpoint Inhibitor-Induced Colitis.
Inflamm Bowel Dis. 2025 Apr 21:izaf065. doi: 10.1093.
PubMed

Correction to: Improving Brain-Gut Studies in Crohn's Disease: Methodological Considerations.
Inflamm Bowel Dis. 2025 Apr 17:izaf075. doi: 10.1093.
PubMed

HACKER KS, Friedlander A
Inclusive Inflammatory Bowel Disease Care for Sexual and Gender Minorities: An Urgent Need in Uncertain Times.
Inflamm Bowel Dis. 2025 Apr 16:izaf059. doi: 10.1093.
PubMed

PATEL PV, Goyal A
Editorial: Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Apr 16:izaf049. doi: 10.1093.
PubMed

BULDUKOGLU OC, Ocal S, Cekin AH
Alterations in Pain Perception in Inflammatory Bowel Disease Patients with Psychiatric Comorbidity.
Inflamm Bowel Dis. 2025 Apr 13:izaf074. doi: 10.1093.
PubMed

GROSSBERG LB, Mishra K, Rabinowitz LG, Mecsas-Faxon B, et al
A Multicenter Study to Assess Avoidant/Restrictive Food Intake Disorder in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Apr 13:izaf016. doi: 10.1093.
PubMed Abstract available

REGUEIRO MD, Bewtra M, Dubinsky MC, Branquinho D, et al
Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States.
Inflamm Bowel Dis. 2025 Apr 12:izaf067. doi: 10.1093.
PubMed Abstract available

ZHOU Z, Su J, van Os BW, Plug LG, et al
Stromal Cell Subsets Show Model-Dependent Changes in Experimental Colitis and Affect Epithelial Tissue Repair and Immune Cell Activation.
Inflamm Bowel Dis. 2025;31:1051-1066.
PubMed Abstract available

ARGUELLES-ARIAS F, Rodriguez Gonzalez FJ, Gonzalez Antuna J, Castro Laria L, et al
Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing.
Inflamm Bowel Dis. 2025;31:1003-1009.
PubMed Abstract available

LIN J, Zuo L, Yang B, Yang R, et al
Identification of the M2 Macrophage-associated Gene THBS2 as a Predictive Marker for Inflammatory Cancer Transformation.
Inflamm Bowel Dis. 2025;31:963-974.
PubMed Abstract available

JAIRATH V, Rubin DT, Verstockt B, Cekin AH, et al
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program.
Inflamm Bowel Dis. 2025;31:923-934.
PubMed Abstract available

MUJAGIC Z
Gut Feelings Matter: The Unresolved Questions of Irritable Bowel Syndrome-Like Symptoms in Inflammatory Bowel Disease in Remission.
Inflamm Bowel Dis. 2025 Apr 9:izaf066. doi: 10.1093.
PubMed

ATTAUABI M, Madsen GR, Holm JP, Bendtsen F, et al
Incidence of Osteoporosis and Osteopenia in Newly Diagnosed Inflammatory Bowel Disease: A Population-Based Cohort Study.
Inflamm Bowel Dis. 2025 Apr 8:izaf063. doi: 10.1093.
PubMed Abstract available

ATIA O, Turner D
Letter: Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis-Authors' Reply.
Inflamm Bowel Dis. 2025 Apr 8:izaf071. doi: 10.1093.
PubMed

NEWMAN KL, Wren PA, Long MD, Higgins PDR, et al
Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Apr 8:izaf054. doi: 10.1093.
PubMed Abstract available

LICHTENSTEIN GR, Allegretti JR, Loftus EV Jr, Irving PM, et al
Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program.
Inflamm Bowel Dis. 2025 Apr 4:izae308. doi: 10.1093.
PubMed Abstract available

March 2025

LEE MCM, Farahvash A, Zezos P
Artificial Intelligence for Classification of Endoscopic Severity of Inflammatory Bowel Disease: A Systematic Review and Critical Appraisal.
Inflamm Bowel Dis. 2025 Mar 31:izaf050. doi: 10.1093.
PubMed Abstract available

BRENNER EJ, Zhang X, Mahadevan U, Bryant AG, et al
Risk Factors for Contraceptive Failure and Unintended Pregnancy Among Women With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Mar 14:izaf046. doi: 10.1093.
PubMed

THOMANN AK, Wolf RC
Reply to "Improving Brain-Gut Studies in Crohn's Disease: Methodological Considerations".
Inflamm Bowel Dis. 2025 Mar 13:izaf051. doi: 10.1093.
PubMed

DUNLEAVY K, Raffals L
Total Proctocolectomy Versus Subtotal/Total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Inflamm Bowel Dis. 2025 Mar 13:izaf003. doi: 10.1093.
PubMed

WU J, Wang W
Improving Brain-Gut Studies in Crohn's Disease: Methodological Considerations.
Inflamm Bowel Dis. 2025 Mar 13:izaf055. doi: 10.1093.
PubMed

CERVERA-SECO L, Baldan-Martin M, Fernandez-Tome S, Ortega Moreno L, et al
Characterization of the Regulatory Landscape in Crohn's Disease Reveals microRNA-Associated Alterations that Shape Anti-TNF Response.
Inflamm Bowel Dis. 2025 Mar 11:izaf029. doi: 10.1093.
PubMed Abstract available

DUNLEAVY KA, Rypstra CR, Busciglio I, Eckert D, et al
Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission.
Inflamm Bowel Dis. 2025 Mar 11:izaf043. doi: 10.1093.
PubMed Abstract available

TODA M, Jimbo K, Suzuki M, Nagata M, et al
The Role of Human Leukocyte Antigen Alleles and Maternal Microchimerism in Very-Early-Onset Ulcerative Colitis in Japanese Children.
Inflamm Bowel Dis. 2025 Mar 10:izaf048. doi: 10.1093.
PubMed Abstract available

OLSEN BC, Opheim R, Kristensen VA, Hoivik ML, et al
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort).
Inflamm Bowel Dis. 2025 Mar 10:izaf047. doi: 10.1093.
PubMed Abstract available

MOHAN M, Thoma OM, Sharma S, Sharma G, et al
Longitudinal Monitoring of Inflammatory Bowel Disease in Mice Using Endoscopic Optical Coherence Tomography.
Inflamm Bowel Dis. 2025 Mar 10:izaf045. doi: 10.1093.
PubMed Abstract available

HABERKAMP S, Fischmann D, Wilde J, Strobel D, et al
Superb Microvascular Imaging Is Superior to Doppler Imaging in Ruling Out Ulcerative Colitis Disease Activity.
Inflamm Bowel Dis. 2025 Mar 8:izaf033. doi: 10.1093.
PubMed Abstract available

BARENBOIM A, Weiss TE, Argyriou O, Cohen NA, et al
Evolution of Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis: A Single-Center Retrospective Study.
Inflamm Bowel Dis. 2025 Mar 8:izaf037. doi: 10.1093.
PubMed Abstract available

SCHELL TL, Caldera F
Optimizing Hepatitis B Vaccination Strategies for Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Mar 7:izaf042. doi: 10.1093.
PubMed

PLUMB AA, Moran G, Chowdhury K, Ahmed N, et al
Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn's Disease Commencing Biological Therapy: The Motility Study.
Inflamm Bowel Dis. 2025 Mar 7:izaf023. doi: 10.1093.
PubMed Abstract available

ZHANG L, Liu Q, Yang X, Su C, et al
Mechanosensitive Ion Channel PIEZO1 as a Key Regulator of Intestinal Fibrosis in Crohn's Disease.
Inflamm Bowel Dis. 2025 Mar 7:izaf041. doi: 10.1093.
PubMed Abstract available

LOPES EW, Yu Z, Walsh SE, Casey K, et al
Dietary Nut and Legume Intake and Risk of Crohn's Disease and Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Mar 4:izaf032. doi: 10.1093.
PubMed Abstract available

KUMAR A, Husain N, Anbazhagan AN, Jayawardena D, et al
Dexamethasone Upregulates the Expression of the Human SLC26A3 (DRA, Down-Regulated in Adenoma) Transporter (an IBD Susceptibility Gene) in Intestinal Epithelial Cells and Attenuates Gut Inflammation.
Inflamm Bowel Dis. 2025;31:625-635.
PubMed Abstract available

VERSTOCKT S, Hannes L, Jans DS, Deman S, et al
MIP4IBD: An Easy and Rapid Genotyping-by-Sequencing Assay for the Inflammatory Bowel Diseases Risk Loci.
Inflamm Bowel Dis. 2025;31:786-799.
PubMed Abstract available

LOWELL JA, Sharma G, Swaminath A, Sultan K, et al
Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis.
Inflamm Bowel Dis. 2025;31:725-732.
PubMed Abstract available

SILVERMAN AL, Bhasuran B, Mosenia A, Yasini F, et al
Accurate, Robust, and Scalable Machine Abstraction of Mayo Endoscopic Subscores From Colonoscopy Reports.
Inflamm Bowel Dis. 2025;31:665-670.
PubMed Abstract available

MALTER L, Hong SJ, Lopatin S, Murphy M, et al
Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience.
Inflamm Bowel Dis. 2025;31:746-750.
PubMed Abstract available

February 2025

SANDS BE, Dubinsky MC, Kotze PG, Vermeire S, et al
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program.
Inflamm Bowel Dis. 2025 Feb 28:izaf036. doi: 10.1093.
PubMed Abstract available

EHRLICH S, Long M, Kane S, Mahadevan U, et al
Placental Transfer of Upadacitinib Among Pregnant Women with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Feb 21:izaf027. doi: 10.1093.
PubMed

VERMEER E, Struys EA, Lin M, van Limbergen JE, et al
Erythrocyte Methotrexate-Polyglutamate Concentrations in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Feb 21:izaf035. doi: 10.1093.
PubMed Abstract available

WILS P, Habibi Kavashkohie MR, Selos Guerra F, Landais S, et al
Single-Cell Transcriptomic Profile of Innate Cell Populations in Mesenteric Lymph Nodes of Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2025 Feb 21:izaf017. doi: 10.1093.
PubMed Abstract available

LIN K, Feng W, Li S
Addressing the Challenges of Inflammatory Bowel Disease-Primary Sclerosing Cholangitis Treatment: Prognosis Optimization Strategies in the Era of Precision Medicine.
Inflamm Bowel Dis. 2025 Feb 20:izaf007. doi: 10.1093.
PubMed

NAKAMURA A, Jimbo K, Suzuki M, Hibio M, et al
Impact of Psychosocial and Neurodevelopmental Disorders on Pediatric Ulcerative Colitis: A Single-Center, Retrospective, Observational Study.
Inflamm Bowel Dis. 2025 Feb 20:izaf034. doi: 10.1093.
PubMed Abstract available

ACHARJEE A, Shivaji U, Santacroce G, Akiror S, et al
Novel Transcriptomic Signatures in Fibrostenotic Crohn's Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets.
Inflamm Bowel Dis. 2025 Feb 20:izaf021. doi: 10.1093.
PubMed Abstract available

JACOBSEN GE, Gonzalez EE, Mendygral P, Faust KM, et al
Deep Sequencing of Crohn's Disease Lamina Propria Phagocytes Identifies Pathobionts and Correlates With Pro-Inflammatory Gene Expression.
Inflamm Bowel Dis. 2025 Feb 14:izae316. doi: 10.1093.
PubMed Abstract available

KIOROGLOU D, Pena-Cearra A, Corraliza AM, Seoane I, et al
Mitochondrial Dysfunction: Unraveling the Elusive Biology Behind Anti-TNF Response During Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Feb 13:izaf015. doi: 10.1093.
PubMed Abstract available

HOWE CS, Chulkina M, Syrcle R, McAninch C, et al
MK2 Inhibition in CD4+ T Cells Protects Against IFNgamma and IL-17A, Chronic Inflammation, and Fibrosis in Inflammatory Bowel Disease Models.
Inflamm Bowel Dis. 2025 Feb 12:izaf026. doi: 10.1093.
PubMed Abstract available

Correction to: Estimation of the Harvey Bradshaw Index from the Patient Reported Outcome-2 in Crohn's Disease.
Inflamm Bowel Dis. 2025 Feb 11:izaf014. doi: 10.1093.
PubMed

LOPETUSO LR, Deleu S, Puca P, Abreu MT, et al
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference.
Inflamm Bowel Dis. 2025 Feb 11:izaf013. doi: 10.1093.
PubMed Abstract available

KALAFATELI M, Tourkochristou E, Tsounis EP, Aggeletopoulou I, et al
New Insights into the Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Diseases: Focusing on Intestinal Smooth Muscle Cells.
Inflamm Bowel Dis. 2025;31:579-592.
PubMed Abstract available

LEVINE I, Sekhri S, Schreiber-Stainthorp W, Locke B, et al
GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD.
Inflamm Bowel Dis. 2025;31:467-475.
PubMed Abstract available

MISHIMA T, Fujimoto M, Urushima H, Funajima E, et al
A Role for Leucine-Rich alpha2-Glycoprotein in Leukocyte Trafficking and Mucosal Inflammation in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Feb 7:izaf022. doi: 10.1093.
PubMed Abstract available

CHIEPPA M, De Santis S, Verna G
Winnie Mice: A Chronic and Progressive Model of Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Feb 6:izaf006. doi: 10.1093.
PubMed Abstract available

VAN LINSCHOTEN RCA, van der Woude CJ, Visser E, van Leeuwen N, et al
Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study.
Inflamm Bowel Dis. 2025;31:332-343.
PubMed Abstract available

KRUGLIAK CLEVELAND N, Bhondwe KS, Duty CM, Rubin DT, et al
Intestinal Ultrasound Identified Crohn's Disease In Previously Undiagnosed Siblings.
Inflamm Bowel Dis. 2025 Feb 4:izaf019. doi: 10.1093.
PubMed

FRIEDMAN S, Garvik OS, Nielsen J, Jolving LR, et al
The Consequences of Preterm Birth in the Children of Mothers with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Inflamm Bowel Dis. 2025 Feb 3:izaf010. doi: 10.1093.
PubMed Abstract available

January 2025

KORNELSEN J, McIver TA, Marrie RA, Patel R, et al
Resting-State Functional Connectivity of the Cerebellum Differs Between Persons With Inflammatory Bowel Disease and Healthy Controls in Relation to Executive Function.
Inflamm Bowel Dis. 2025 Jan 31:izaf020. doi: 10.1093.
PubMed

CHHIBBA T, Frolkis A, Stein LR, Lee S, et al
Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Jan 30:izaf012. doi: 10.1093.
PubMed Abstract available

ROSEIRA J, Jairath V
Bridging the Gap Between Explanatory and Pragmatic Trials in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2025 Jan 28:izae314. doi: 10.1093.
PubMed

TAKEDOMI H, Nunomura S, Nanri Y, Honda Y, et al
Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Jan 27:izaf009. doi: 10.1093.
PubMed Abstract available

ALLEGRETTI JR, Feuerstadt P, Knapple WL, Orenstein R, et al
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA(R)), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS.
Inflamm Bowel Dis. 2025 Jan 25:izae291. doi: 10.1093.
PubMed Abstract available

DILLMAN JR, Tkach JA, Fletcher JG, Bruining DH, et al
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease.
Inflamm Bowel Dis. 2025 Jan 24:izae319. doi: 10.1093.
PubMed Abstract available

QIN X
Emerging Connections Between Inflammatory Bowel Disease Subtypes and Sequential Changes in Total Serum Bilirubin.
Inflamm Bowel Dis. 2025 Jan 20:izaf004. doi: 10.1093.
PubMed

GOLAN-GERSTL R, Ben Ya'acov A, Musseri M, Goldenberg R, et al
Expression Profile of MicroRNAs in Breast Milk of Women With Inflammatory Bowel Disease: Correlation With Disease Activity and Medical Treatments.
Inflamm Bowel Dis. 2025 Jan 17:izae290. doi: 10.1093.
PubMed Abstract available

WEINTRAUB Y, Collen LV, Hussey S, Mitrova K, et al
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology an
Inflamm Bowel Dis. 2025 Jan 15:izae302. doi: 10.1093.
PubMed Abstract available

THOMANN AK, Schmitgen MM, Stephan JC, Knoedler LL, et al
Disease-State Dependent Associations Between Intrinsic Brain Function and Symptoms of Fatigue, Depression, and Anxiety in Crohn's Disease.
Inflamm Bowel Dis. 2025 Jan 15:izae318. doi: 10.1093.
PubMed Abstract available

SUGIYAMA Y, Konishi H, Dokoshi T, Tanaka H, et al
hsa_circ_0015388 Reduces Macrophage Derived Reactive Oxygen Species in Crohn's Disease.
Inflamm Bowel Dis. 2025 Jan 13:izae317. doi: 10.1093.
PubMed Abstract available

NISHIDA Y, Hosomi S, Fujimoto K, Kobayashi Y, et al
Impact of 5-Aminosalicylic Acid on Ustekinumab in Inflammatory Bowel Disease: A Retrospective Medical Claims Analysis.
Inflamm Bowel Dis. 2025 Jan 11:izaf001. doi: 10.1093.
PubMed Abstract available

ZHANG X
Postpartum Wound Healing for Mothers with Inflammatory Bowel Disease: Cause for Worry? Insights from the Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Registry.
Inflamm Bowel Dis. 2025 Jan 8:izae309. doi: 10.1093.
PubMed

LIU Y, Sha S, Ran Q, Shi H, et al
The Correlation Between Fecal Amino Acids, Colonic Mucosal Taste Receptors, and Clinical Features and Indicators of Ulcerative Colitis: A Multicenter Exploratory Study.
Inflamm Bowel Dis. 2025 Jan 7:izae299. doi: 10.1093.
PubMed Abstract available

ESAI SELVAN M, Nathan DI, Guisado D, Collatuzzo G, et al
Clonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Jan 6:izae312. doi: 10.1093.
PubMed Abstract available

ARUMUGAM P, Saha K, Nighot P
Intestinal Epithelial Tight Junction Barrier Regulation by Novel Pathways.
Inflamm Bowel Dis. 2025;31:259-271.
PubMed Abstract available

LING F, Chen Y, Li J, Xu M, et al
Estrogen Receptor beta Activation Mitigates Colitis-associated Intestinal Fibrosis via Inhibition of TGF-beta/Smad and TLR4/MyD88/NF-kappaB Signaling Pathways.
Inflamm Bowel Dis. 2025;31:11-27.
PubMed Abstract available

UCHINO T, Lincango EP, Hernandez Dominguez O, Bhama A, et al
Rediversion of the Failing Ileoanal Pouch: First Step in Pouch Salvage?
Inflamm Bowel Dis. 2025;31:105-112.
PubMed Abstract available

PLECHSCHMIDT J, Fietkau K, Hepp T, Dietrich P, et al
Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial.
Inflamm Bowel Dis. 2025;31:77-86.
PubMed Abstract available

DAUNGSUPAWONG H, Wiwanitkit V
Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis.
Inflamm Bowel Dis. 2025 Jan 2:izae315. doi: 10.1093.
PubMed

December 2024

DESAI A, Kochhar GS
Letter: Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: Authors' Reply.
Inflamm Bowel Dis. 2024 Dec 27:izae304. doi: 10.1093.
PubMed

VISSERS E, Wellens J, Giorio L, Zadora W, et al
Dietary Carrageenan Amplifies the Inflammatory Profile, but not Permeability, of Intestinal Epithelial Cells from Patients With Crohn's Disease.
Inflamm Bowel Dis. 2024 Dec 24:izae306. doi: 10.1093.
PubMed Abstract available

LELONG M, Bourreille A, Mosnier JF, Trang-Poisson C, et al
Acute Severe Ulcerative Colitis and Cytomegalovirus During Pregnancy: A Case Report.
Inflamm Bowel Dis. 2024 Dec 24:izae313. doi: 10.1093.
PubMed

GIBSON G, Rioux JD, Cho JH, Haritunians T, et al
Eleven Grand Challenges for Inflammatory Bowel Disease Genetics and Genomics.
Inflamm Bowel Dis. 2024 Dec 19:izae269. doi: 10.1093.
PubMed Abstract available

LUND C, Strande V, Hagen M, Bengtson MB, et al
Low Surgery Rates in Early Crohn's Disease: Results from a Prospective Population-Based Inception Cohort-The Inflammatory Bowel Disease in South-Eastern Norway III Study.
Inflamm Bowel Dis. 2024 Dec 19:izae297. doi: 10.1093.
PubMed Abstract available

UKASHI O, Lahat A, Ungar B, Veisman I, et al
Intestinal Ultrasound Measures are Strongly Correlated With Small Bowel Endoscopic Lewis Score in Active Crohn's Disease.
Inflamm Bowel Dis. 2024 Dec 19:izae296. doi: 10.1093.
PubMed Abstract available

LEGA S, Bramuzzo M
Advancing Toward Transmural Healing in Pediatric Crohn's Disease.
Inflamm Bowel Dis. 2024 Dec 17:izae224. doi: 10.1093.
PubMed

SCARALLO L, McKay HE, Schneider R, Ricciuto A, et al
Improvement of Transmural Inflammation With Adalimumab Versus Immunomodulator Maintenance Therapy in Pediatric Crohn's Disease: Single-Center Prospective Evaluation Using the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index.
Inflamm Bowel Dis. 2024 Dec 17:izae227. doi: 10.1093.
PubMed Abstract available

KAMP K, Yang PL, Tsai CS, Zhang X, et al
Gender and Sex Differences in Abdominal Pain, Fatigue, And Psychological Symptoms Among Adults with Inflammatory Bowel Disease: A Network Analysis.
Inflamm Bowel Dis. 2024 Dec 13:izae279. doi: 10.1093.
PubMed Abstract available

SCOTT G, Wands DIF, Wilson DC, Hansen R, et al
Selecting High-Risk Patients With Pediatric Crohn's Disease for Top-Down Anti-TNF as per the 2021 ECCO-ESPGHAN Guidelines: A 5-Year Nationwide Retrospective Analysis From Scotland (2016-2020).
Inflamm Bowel Dis. 2024 Dec 13:izae298. doi: 10.1093.
PubMed Abstract available

NAKANISHI R, Kuwada T, Shiokawa M, Nishikawa Y, et al
Anti-integrin alphavbeta6 Antibodies Predict Pouchitis in Patients With Ulcerative Colitis After Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2024 Dec 6:izae263. doi: 10.1093.
PubMed Abstract available

SHARIP MT, Parkes M, Subramanian S
Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Inflamm Bowel Dis. 2024;30:2521-2522.
PubMed Abstract available

LAGRANGE J, Ahmed MU, Arnone D, Lacolley P, et al
Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis.
Inflamm Bowel Dis. 2024;30:2500-2508.
PubMed Abstract available

GU P, Mendonca O, Carter D, Dube S, et al
AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD.
Inflamm Bowel Dis. 2024;30:2467-2485.
PubMed Abstract available

THAPWONG P, Norton C, Rowland E, Czuber-Dochan W, et al
Our Life Is a Rollercoaster! A Qualitative Phenomenological Study Exploring the Impact of IBD on Family Members.
Inflamm Bowel Dis. 2024;30:2395-2404.
PubMed Abstract available

DERBEY L, Charlois AL, Buisson A, Roblin X, et al
Physical Activity and IBD: State of Art and Knowledge, Patients and Healthcare Professionals Points of View, A French Multicenter Cross Sectional Study.
Inflamm Bowel Dis. 2024;30:2306-2313.
PubMed Abstract available

VESTERGAARD T, Holm Meiltoft I, Julsgaard M, Bek Helmig R, et al
Preterm Birth and in Utero Exposure to Corticosteroids Are Associated With Increased Infection Risk in Children of Mothers With IBD.
Inflamm Bowel Dis. 2024;30:2297-2305.
PubMed Abstract available

ZHAO M, Riis LB, Lo B, Attauabi M, et al
Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With Biologics.
Inflamm Bowel Dis. 2024 Dec 4:izae287. doi: 10.1093.
PubMed Abstract available

NAKASE H, Danese S, Reinisch W, Ritter T, et al
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study.
Inflamm Bowel Dis. 2024 Dec 4:izae278. doi: 10.1093.
PubMed Abstract available

KHANNA R, Son S, Zou G, Roshanov PS, et al
Estimation of the Harvey Bradshaw Index from the Patient-Reported Outcome 2 in Crohn's Disease: Results Based on a Large Scale Randomized Controlled Trial.
Inflamm Bowel Dis. 2024 Dec 4:izae281. doi: 10.1093.
PubMed Abstract available

Correction to: Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch.
Inflamm Bowel Dis. 2024 Dec 4:izae295. doi: 10.1093.
PubMed

November 2024

DULAI PS, Johnson E, Cox K, Eldasher LM, et al
Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Nov 29:izae270. doi: 10.1093.
PubMed Abstract available

YANG E, Wayne PM, Ahn AC, Korzenik J, et al
Potential Utility of Laser Speckle Contrast Imaging to Detect Early Microcirculatory Changes Associated With Erythema Nodosum in Crohn's Disease: A Case Report.
Inflamm Bowel Dis. 2024 Nov 28:izae284. doi: 10.1093.
PubMed

SHARIF K, Ben-Horin S, Lahat A
Eco-gastroenterology in Inflammatory Bowel Disease Treatment: A Call for Sustainable Healthcare.
Inflamm Bowel Dis. 2024 Nov 27:izae280. doi: 10.1093.
PubMed

NIELSEN J, Friedman S, Norgard BM, Knudsen T, et al
Glucagon-Like Peptide 1 Receptor Agonists Are Not Associated With an Increased Risk of Ileus or Intestinal Obstruction in Patients with Inflammatory Bowel Disease-A Danish Nationwide Cohort Study.
Inflamm Bowel Dis. 2024 Nov 27:izae276. doi: 10.1093.
PubMed Abstract available

MANESS SB
Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Call to Action to Improve Patient Care.
Inflamm Bowel Dis. 2024 Nov 23:izae277. doi: 10.1093.
PubMed

GOLOB J, Rao K, Berinstein JA, Singh P, et al
Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways.
Inflamm Bowel Dis. 2024 Nov 14:izae238. doi: 10.1093.
PubMed Abstract available

HARVEY PR, McNulty D, Coupland B, Kemos P, et al
The Risk of Venous Thromboembolism in Children With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Nov 14:izae249. doi: 10.1093.
PubMed Abstract available

FISCHMAN M, Godny L, Friedenberg A, Barkan R, et al
Factors Associated With Biologic Therapy After Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Nov 14:izae272. doi: 10.1093.
PubMed Abstract available

QAPAJA T, Abu-Rumaileh M, Alsabbagh Alchirazi K, Gharaibeh A, et al
Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Nov 13:izae267. doi: 10.1093.
PubMed Abstract available

Correction to: Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.
Inflamm Bowel Dis. 2024 Nov 13:izae252. doi: 10.1093.
PubMed

SALWEN-DEREMER JK, Westvold SJ, Siegel CA, Smith MT, et al
The Bidirectional Relationship Between Sleep and Pain in Crohn's Disease: A Daily Diary Study.
Inflamm Bowel Dis. 2024 Nov 12:izae265. doi: 10.1093.
PubMed Abstract available

FANSIWALA K, Limketkai BN
Stricturing Crohn's Disease: When Biologics May Help or Not?
Inflamm Bowel Dis. 2024 Nov 12:izae264. doi: 10.1093.
PubMed

KOJIMA T, Kurachi K, Tatsuta K, Sugiyama K, et al
Myosteatosis Evaluated Based on Intramuscular Adipose Tissue Content Is a Risk Factor for Postoperative Complications in Crohn's Disease.
Inflamm Bowel Dis. 2024 Nov 11:izae247. doi: 10.1093.
PubMed Abstract available

EDWARDS TS, Ho SSC, Brown SC, Appleton L, et al
Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Crohn's Disease.
Inflamm Bowel Dis. 2024 Nov 11:izae262. doi: 10.1093.
PubMed Abstract available

MASSIRONI S, Danese S
Reply: MIND the Gap: Psychiatric Conditions in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Nov 5:izae258. doi: 10.1093.
PubMed

BRODERSEN JB, Rafaelsen SR, Juel MA, Knudsen T, et al
Assessment of Treatment Response in Known Crohn's Disease-A Prospective Blinded Study Comparing the Diagnostic Accuracy of Intestinal Ultrasound, Magnetic Resonance Enterocolonography, Panenteric Capsule Endoscopy, and Fecal Calprotectin.
Inflamm Bowel Dis. 2024 Nov 4:izae254. doi: 10.1093.
PubMed Abstract available

ARBABZADA N, Dennett L, Meng G, Peerani F, et al
The Effectiveness of Oral Vancomycin on Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis: A Systematic Review.
Inflamm Bowel Dis. 2024 Nov 4:izae257. doi: 10.1093.
PubMed Abstract available

KOKKOTIS G, Filidou E, Tarapatzi G, Spathakis M, et al
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts.
Inflamm Bowel Dis. 2024;30:2162-2173.
PubMed Abstract available

LIU J, Xu L, Wang L, Wang Q, et al
Naringin Alleviates Intestinal Fibrosis by Inhibiting ER Stress-Induced PAR2 Activation.
Inflamm Bowel Dis. 2024;30:1946-1956.
PubMed Abstract available

ROSHANOV PS, Khanna R
The Clinical Interpretation of Noninferiority Trials.
Inflamm Bowel Dis. 2024;30:2191-2194.
PubMed Abstract available

HOELZ H, Bragagna L, Litwin A, Koletzko S, et al
Pediatric IBD Patients Treated With Infliximab and Proactive Drug Monitoring Benefit From Early Concomitant Immunomodulatory Therapy: A Retrospective Analysis of a 10-Year Real-Life Cohort.
Inflamm Bowel Dis. 2024;30:2004-2018.
PubMed Abstract available

Correction to: TOpClass Class 4 Perineal Crohn's Disease: A Systematic Review and Meta-analysis of Perineal Wound Complication After Proctectomy in Crohn's Patients.
Inflamm Bowel Dis. 2024 Nov 2:izae268. doi: 10.1093.
PubMed

October 2024

KOCHHAR GS, Khataniar H, Hashash JG, Tabaku F, et al
Comparative Effectiveness of Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: A Propensity-Matched Cohort Analysis.
Inflamm Bowel Dis. 2024 Oct 30:izae251. doi: 10.1093.
PubMed Abstract available

MACALUSO FS, Renna S, Fries W, Viola A, et al
The Effectiveness of Risankizumab as Induction Therapy for Crohn's Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2024 Oct 26:izae248. doi: 10.1093.
PubMed

SANDS BE, D'Haens G, Clemow DB, Irving PM, et al
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Inflamm Bowel Dis. 2024 Oct 25:izae253. doi: 10.1093.
PubMed Abstract available

BAYOUMY AB, Derijks LJJ, de Boer NKH
DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Oct 24:izae234. doi: 10.1093.
PubMed

CAO D, Hu M, Yang N, Qian K, et al
Microbial and Transcriptomic Landscape Associated With Neutrophil Extracellular Traps in Perianal Fistulizing Crohn's Disease.
Inflamm Bowel Dis. 2024 Oct 22:izae202. doi: 10.1093.
PubMed Abstract available

SHAHIN TB, Khan N, Malik TA
Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch.
Inflamm Bowel Dis. 2024 Oct 22:izae241. doi: 10.1093.
PubMed

POULSEN A, Alexdottir MS, Riis LB, Pehrsson M, et al
Circulating Extracellular Matrix Products as Indicators of Disease Burden and Predictors of Disease Course in Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Oct 22:izae244. doi: 10.1093.
PubMed Abstract available

LIU F, Ai F, Tang A, Yang Z, et al
Macrophage-Derived Exosomes Promoted the Development and Stemness of Inflammatory Bowel Disease-Related Colorectal Cancer via nuclear paraspeckle assembly transcript 1-Mediated miRNA-34a-5p/phosphoprotein enriched in astrocytes 15 Axis.
Inflamm Bowel Dis. 2024 Oct 19:izae212. doi: 10.1093.
PubMed Abstract available

KUMAR A, Quraishi MN, Al-Hassi HO, Elasrag M, et al
The Effect of Colesevelam on the Microbiome in Postoperative Crohn's Disease.
Inflamm Bowel Dis. 2024 Oct 18:izae230. doi: 10.1093.
PubMed Abstract available

NICHOLS B, Russell RK, Short B, Papadopoulou R, et al
Gut Microbial Signatures in Pediatric Crohn's Disease Vary According to Disease Activity Measures and Are Influenced by Proxies of Gastrointestinal Transit Time: An ImageKids Study.
Inflamm Bowel Dis. 2024 Oct 17:izae199. doi: 10.1093.
PubMed Abstract available

DA SILVA BC, Papasotiriou S, Hanauer SB
Corticosteroid Use in Randomized Clinical Trials of Biologics and Small Molecules in Inflammatory Bowel Disease: A Systematic Review.
Inflamm Bowel Dis. 2024 Oct 17:izae240. doi: 10.1093.
PubMed Abstract available

MOSES J, Adler J, Saeed SA, Firestine AM, et al
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.
Inflamm Bowel Dis. 2024 Oct 17:izae239. doi: 10.1093.
PubMed Abstract available

KASTL AJ, Brenner EJ, Weaver KN, Zhang X, et al
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Oct 16:izae225. doi: 10.1093.
PubMed Abstract available

HASSAN B, Suchan A, Brown M, Kishan A, et al
The Impact of Hormone Therapy on Inflammatory Bowel Disease in Transgender and Nonbinary Individuals.
Inflamm Bowel Dis. 2024 Oct 16:izae236. doi: 10.1093.
PubMed Abstract available

CHAABAN L, Cohen B, Cross RK, Kayal M, et al
Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort.
Inflamm Bowel Dis. 2024 Oct 9:izae193. doi: 10.1093.
PubMed Abstract available

JORDAN AA, Bhat S, Ali T, Brunskill SR, et al
Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn's & Colitis Foundation.
Inflamm Bowel Dis. 2024 Oct 8:izae237. doi: 10.1093.
PubMed Abstract available

HYAMS JS, Winter HS, Mulberg AE, Zuckerman E, et al
An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Oct 8:izae226. doi: 10.1093.
PubMed

ALIPOURIANI A, Erozkan K, Schabl L, Sancheti H, et al
TOpClass Class 4 Perineal Crohn's Disease: A Systematic Review and Meta-analysis of Perineal Wound Complication After Proctectomy in Crohn's Patients.
Inflamm Bowel Dis. 2024 Oct 8:izae198. doi: 10.1093.
PubMed Abstract available

GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
Response to the Letter to the Editor, "Refining the Understanding of Cannabis Impact on Inflammatory Bowel Disease Outcomes: Recommendations for Enhanced Research and Healthcare Practices".
Inflamm Bowel Dis. 2024 Oct 3:izae228. doi: 10.1093.
PubMed

COELHO T, Cheng G, Vazquez Lopez F, Ashton JJ, et al
Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Inflamm Bowel Dis. 2024;30:1928-1930.
PubMed

MASPERO M, Otero A, Lavryk O, Holubar SD, et al
Incidental Dysplasia During Total Proctocolectomy With Ileoanal Pouch: Is It Associated With Worse Outcomes?
Inflamm Bowel Dis. 2024;30:1740-1747.
PubMed Abstract available

Correction to: Endoscopic Skipping, Stricturing, and Penetrating Complications in Crohn's Disease on Tandem Ileo-colonoscopy and Cross-sectional Imaging: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2024 Oct 1:izae246. doi: 10.1093.
PubMed

September 2024

CARVALHO T, Pinto J, Araujo J, Fernandes D, et al
Challenges in the Management of Acute Severe Ulcerative Colitis in a Patient With Guillain-Barre Syndrome Associated With Infliximab.
Inflamm Bowel Dis. 2024 Sep 28:izae235. doi: 10.1093.
PubMed

GE H, Wang C, Zhao H, Chen H, et al
Targeting NCAPD2 as a Therapeutic Strategy for Crohn's Disease: Implications for Autophagy and Inflammation.
Inflamm Bowel Dis. 2024 Sep 28:izae211. doi: 10.1093.
PubMed Abstract available

ODUFALU FD, Gonzalez S, Hurtado ACM, Hsiao J, et al
A Review of Cutaneous Extraintestinal Manifestations of Inflammatory Bowel Disease in Skin of Color.
Inflamm Bowel Dis. 2024 Sep 28:izae222. doi: 10.1093.
PubMed Abstract available

PORTH R, Deyhim T, Geeganage G, Smith B, et al
Proactive Therapeutic Drug Monitoring of Ustekinumab Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Sep 26:izae231. doi: 10.1093.
PubMed Abstract available

UZZAN M, Georgiev G, Peyrin-Biroulet L, Bouhnik Y, et al
Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients.
Inflamm Bowel Dis. 2024 Sep 26:izae233. doi: 10.1093.
PubMed Abstract available

ARMUZZI A, Rubin DT, Schreiber S, Panes J, et al
Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.
Inflamm Bowel Dis. 2024 Sep 26:izae229. doi: 10.1093.
PubMed Abstract available

Correction to: Consensus Statement on Managing Anxiety and Depression in Individuals with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Sep 25:izae243. doi: 10.1093.
PubMed

WANDS DIF, Gianolio L, Cameron F, Hansen R, et al
Pediatric Inflammatory Bowel Disease Type Unclassified: A Nationwide Cohort Study in Scotland With up to 20 Years Follow-up Shows Reclassification in the Majority and Mild Course in Those Whose Diagnosis Is Unchanged.
Inflamm Bowel Dis. 2024 Sep 25:izae218. doi: 10.1093.
PubMed Abstract available

HUSSAIN FS, Potlach T, Chi X, Gurka MJ, et al
Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Sep 25:izae219. doi: 10.1093.
PubMed Abstract available

RIPOLLES T, Poza J, Martinez-Perez MJ, Suarez Ferrer C, et al
Evaluation of Crohn's Disease Activity: Validation of a Segmental Simple Ultrasound Score in a Multicenter Study.
Inflamm Bowel Dis. 2024 Sep 21:izae213. doi: 10.1093.
PubMed Abstract available

DALAL RS
Limiting Opioid Use for Patients Who Are Hospitalized for Inflammatory Bowel Disease Exacerbations.
Inflamm Bowel Dis. 2024 Sep 19:izae214. doi: 10.1093.
PubMed

KARLOVICH N, McConnell R, Velayos F, Mahadevan U, et al
Opioid Use and Outcomes in Patients Hospitalized With Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Sep 18:izae216. doi: 10.1093.
PubMed Abstract available

RUBIN DT, Kubassova O, Weber CR, Adsul S, et al
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Sep 16:izae204. doi: 10.1093.
PubMed Abstract available

Correction to: Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD.
Inflamm Bowel Dis. 2024 Sep 14:izae217. doi: 10.1093.
PubMed

GUO A, Ludvigsson J, Hard Af Segerstad EM, Brantsaeter AL, et al
Early-Life Diet Diversity and the Subsequent Risk of Inflammatory Bowel Disease: Findings From Two Scandinavian Birth Cohorts.
Inflamm Bowel Dis. 2024 Sep 13:izae210. doi: 10.1093.
PubMed Abstract available

PAPADOPOULOS V, Skendros P
On the Association Between the E148Q Single-nucleotide Polymorphism of the MEFV Gene and Crohn's Disease.
Inflamm Bowel Dis. 2024 Sep 12:izae178. doi: 10.1093.
PubMed

AZIZ S, Akhlaq A, Owings A, Gurz S, et al
Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020.
Inflamm Bowel Dis. 2024 Sep 11:izae184. doi: 10.1093.
PubMed Abstract available

KELUTH CHAVAN A, Jha P, Perez JA, Harper E, et al
Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study.
Inflamm Bowel Dis. 2024 Sep 11:izae203. doi: 10.1093.
PubMed

GUO A, Ludvigsson J, Lerchova T, Imberg H, et al
Association Between Maternal Infections in Pregnancy and the Risk of Inflammatory Bowel Disease in the Offspring: Findings From Two Scandinavian Birth Cohorts.
Inflamm Bowel Dis. 2024 Sep 9:izae209. doi: 10.1093.
PubMed Abstract available

GUO X, Zhao Z, Wang Y
Refining the Understanding of Cannabis Impact on Inflammatory Bowel Disease Outcomes: Recommendations for Enhanced Research and Healthcare Practices.
Inflamm Bowel Dis. 2024 Sep 6:izae207. doi: 10.1093.
PubMed

PANES J, Louis E, Bossuyt P, Joshi N, et al
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2024 Sep 4:izae200. doi: 10.1093.
PubMed Abstract available

BERNSTEIN CN, Fisk JD, Walld R, Bolton JM, et al
Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population.
Inflamm Bowel Dis. 2024 Sep 3:izae188. doi: 10.1093.
PubMed Abstract available

WANG S, Xu Y, Wang L, Lin J, et al
TolDC Restores the Balance of Th17/Treg via Aryl Hydrocarbon Receptor to Attenuate Colitis.
Inflamm Bowel Dis. 2024;30:1546-1555.
PubMed Abstract available

GONZALEZ CG, Stevens TW, Verstockt B, Gonzalez DJ, et al
Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab.
Inflamm Bowel Dis. 2024;30:1536-1545.
PubMed Abstract available

HE JZ, Hirschtritt ME, Wei J, Ramalingam ND, et al
Psychiatric Diagnoses, Medication, and Service Use Among Patients Who Receive Emergency Care for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2024;30:1619-1622.
PubMed

August 2024

SOLITANO V, Vuyyuru SK, Aruljothy A, Alkhattabi M, et al
Endoscopic Skipping, Stricturing, and Penetrating Complications in Crohn's Disease on Tandem Ileo-colonoscopy and Cross-sectional Imaging: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2024 Aug 31:izae192. doi: 10.1093.
PubMed Abstract available

MAHADEVAN U, Long M
Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Aug 31:izae182. doi: 10.1093.
PubMed

HILLEY P, Wong D, De Cruz P
How Does an Integrated Pharmacist Add Value in the Management of Inflammatory Bowel Disease in the Era of Values-Based Healthcare?
Inflamm Bowel Dis. 2024 Aug 29:izae196. doi: 10.1093.
PubMed Abstract available

CHAN P, McNamara J, Vernon-Roberts A, Giles EM, et al
Systematic Review: Practices and Programs in Inflammatory Bowel Disease Transition Care.
Inflamm Bowel Dis. 2024 Aug 28:izae190. doi: 10.1093.
PubMed Abstract available

KANG H, Schmoyer CJ, Weiss A, Lewis JD, et al
Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Aug 28:izae158. doi: 10.1093.
PubMed Abstract available

JUN YK, Oh HJ, Lee JA, Choi Y, et al
The Potential of Molecular Remission: Tissue Neutrophil Elastase Is Better Than Histological Activity for Predicting Long-Term Relapse in Patients With Ulcerative Colitis in Endoscopic Remission.
Inflamm Bowel Dis. 2024 Aug 27:izae194. doi: 10.1093.
PubMed Abstract available

DRAGASEVIC S, Stankovic B, Kotur N, Sokic Milutinovic A, et al
Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation.
Inflamm Bowel Dis. 2024 Aug 27:izae180. doi: 10.1093.
PubMed Abstract available

GSENGER V, Rodriguez A, Araka E, Oza F, et al
A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Aug 27:izae197. doi: 10.1093.
PubMed Abstract available

DAMIANOS JA, Osikoya O, Brennan G
Upadacitinib for Acute Severe Ulcerative Colitis: A Systematic Review.
Inflamm Bowel Dis. 2024 Aug 26:izae191. doi: 10.1093.
PubMed Abstract available

GROSEN A, Bellaguarda E, Liljeqvist-Soltic I, Skytte AB, et al
Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Aug 23:izae195. doi: 10.1093.
PubMed

MINAWALA R, Kim M, Delau O, Ghiasian G, et al
Sarcopenia Is a Risk Factor for Postoperative Complications Among Older Adults With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Aug 23:izae187. doi: 10.1093.
PubMed Abstract available

DAY AS, Ballard TM, Yao CK, Gibson PR, et al
Food-Based Interventions as Therapy for Inflammatory Bowel Disease: Important Steps in Diet Trial Design and Reporting of Outcomes.
Inflamm Bowel Dis. 2024 Aug 23:izae185. doi: 10.1093.
PubMed Abstract available

HINNANT L, Rios Villacorta N, Chen E, Bacchus D, et al
Consensus Statement on Managing Anxiety and Depression in Individuals with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Aug 22:izae151. doi: 10.1093.
PubMed Abstract available

NEIMAN N, Boothroyd D, Anjur K, Bensen R, et al
Self-Compassion in Adolescents and Young Adults With Inflammatory Bowel Disease: Relationship of Self-Compassion to Psychosocial and Physical Outcomes.
Inflamm Bowel Dis. 2024 Aug 21:izae170. doi: 10.1093.
PubMed Abstract available

DALAL RS, Allegretti JR
Reply: In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis.
Inflamm Bowel Dis. 2024 Aug 20:izae181. doi: 10.1093.
PubMed

ATTAUABI M, Burisch J, Nielsen OH, Seidelin JB, et al
In Severe Inflammatory Bowel Disease, the Onset of Effectiveness of Biologics and Small Molecules Depends More on the Medication Than on the Diagnosis.
Inflamm Bowel Dis. 2024 Aug 20:izae183. doi: 10.1093.
PubMed

MALHAM M, Vestergaard MV, Bataillon T, Villesen P, et al
The Composition of the Fecal and Mucosa-adherent Microbiota Varies Based on Age and Disease Activity in Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Aug 16:izae179. doi: 10.1093.
PubMed Abstract available

SHEHAB M, Hassan A, Alrashed F, Abbas A, et al
Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
Inflamm Bowel Dis. 2024 Aug 13:izae163. doi: 10.1093.
PubMed Abstract available

QIU Y, Hu S, Chao K, Huang L, et al
Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn's Disease: Integrating Clinical Characteristics and Longitudinal Laboratory Trends.
Inflamm Bowel Dis. 2024 Aug 10:izae176. doi: 10.1093.
PubMed Abstract available

GISBERT JP, Schreiber S, Siegel CA, Magro F, et al
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study.
Inflamm Bowel Dis. 2024 Aug 10:izae162. doi: 10.1093.
PubMed Abstract available

JUDGE C, Lightowler D, Singh A, Yeap BB, et al
Distribution of Serum Testosterone Concentrations in IBD Males and Associations With Inflammatory Bowel Disease Activity.
Inflamm Bowel Dis. 2024 Aug 7:izae177. doi: 10.1093.
PubMed Abstract available

MARKOPOULOS P, Karmiris K, Dimas I, Voudoukis E, et al
Efficacy of Vaccination and Revaccination Against Hepatitis B Virus Using 2 Different Strategies in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Aug 5:izae173. doi: 10.1093.
PubMed Abstract available

MEKES-ADAMCZYK A, Gausmann N, Oznur O, Pfuhlmann K, et al
Lifestyle Intervention Modulates the CD4+ T Cell Profile in the Blood of Crohn's Disease Patients.
Inflamm Bowel Dis. 2024 Aug 5:izae154. doi: 10.1093.
PubMed Abstract available

LEE CK, Moon W, Chun J, Kim ES, et al
One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn's Disease: The K-STAR Study.
Inflamm Bowel Dis. 2024 Aug 3:izae171. doi: 10.1093.
PubMed Abstract available

GEBEYEHU GG, Broglio G, Liu E, Limdi JK, et al
Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients.
Inflamm Bowel Dis. 2024 Aug 3:izae174. doi: 10.1093.
PubMed Abstract available

WATSON A, Harris RA, Engevik AC, Oezguen N, et al
MYO5B and the Polygenic Landscape of Very Early-Onset Inflammatory Bowel Disease in an Ethnically Diverse Population.
Inflamm Bowel Dis. 2024 Aug 3:izae169. doi: 10.1093.
PubMed Abstract available

REGUEIRO M, Fischer M, Bossuyt P, McGinnis K, et al
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study.
Inflamm Bowel Dis. 2024 Aug 2:izae166. doi: 10.1093.
PubMed Abstract available

DI MATTIA M, Sallese M, Neri M, Lopetuso LR, et al
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1alpha and Microbiota's Crosstalk.
Inflamm Bowel Dis. 2024;30:1406-1418.
PubMed Abstract available

IKEGAMI S, Maeda K, Urano T, Mu J, et al
Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function.
Inflamm Bowel Dis. 2024;30:1353-1366.
PubMed Abstract available

HOSSAIN M, Plietz M, Khaitov S, Sylla P, et al
Pouch Body Anastomotic Ulcerations Are Not Associated With an Increased Risk of Pouchitis.
Inflamm Bowel Dis. 2024;30:1423-1425.
PubMed

BARNES EL, Esckilsen S, Ashburn J, Barto A, et al
Extensive Colitis and Smoking Are Associated With Postoperative Complications Within 30 Days of Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2024;30:1326-1333.
PubMed Abstract available

LIM SH, Gros B, Sharma E, Lehmann A, et al
Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.
Inflamm Bowel Dis. 2024;30:1284-1294.
PubMed Abstract available

July 2024

SANDS BE, Danese S, Chapman JC, Gurjar K, et al
Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease.
Inflamm Bowel Dis. 2024 Jul 31:izae159. doi: 10.1093.
PubMed Abstract available

DE CARVALHO MF, Carlos AS, Kum AST, Bestetti AM, et al
Invasive Therapeutic Strategies for Stricturing Crohn's Disease in Childhood: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024 Jul 24:izae144. doi: 10.1093.
PubMed Abstract available

BEN-TOV A, Achler T, Patalon T, Gazit S, et al
The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children.
Inflamm Bowel Dis. 2024 Jul 24:izae160. doi: 10.1093.
PubMed Abstract available

KAYAL M, Spencer EA, Smyth M, Raffals L, et al
Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch.
Inflamm Bowel Dis. 2024 Jul 22:izae164. doi: 10.1093.
PubMed

KUENZIG ME, Walters TD, Mack DR, Griffiths AM, et al
High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative Data.
Inflamm Bowel Dis. 2024 Jul 19:izae148. doi: 10.1093.
PubMed Abstract available

YZET C, Meudjo E, Brazier F, Hautefeuille V, et al
Intestinal Ultrasound, Fecal Calprotectin, and Their Combination to Predict Endoscopic Mucosal Healing in Ulcerative Colitis: A Real-Life Cross-Sectional Study.
Inflamm Bowel Dis. 2024 Jul 18:izae145. doi: 10.1093.
PubMed Abstract available

REGUEIRO M, Siegmund B, Horst S, Moslin R, et al
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis.
Inflamm Bowel Dis. 2024 Jul 17:izae136. doi: 10.1093.
PubMed Abstract available

COELHO T, Cheng G, Lewis S, Ashton JJ, et al
Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jul 16:izae126. doi: 10.1093.
PubMed Abstract available

DAHIYA DS, Jena A, Bapaye J, Mohan BP, et al
Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024 Jul 16:izae128. doi: 10.1093.
PubMed Abstract available

PETROV JC, Desai AA, Kochhar GS, Crosby SK, et al
Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study.
Inflamm Bowel Dis. 2024 Jul 12:izae147. doi: 10.1093.
PubMed Abstract available

KERBIRIOU C, Dickson C, Nichols B, Logan M, et al
Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products.
Inflamm Bowel Dis. 2024 Jul 9:izae124. doi: 10.1093.
PubMed Abstract available

URQUHART SA, Chedid VG, Kane SV
Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report.
Inflamm Bowel Dis. 2024 Jul 5:izae146. doi: 10.1093.
PubMed

RYAN K, Salozzo C, Schwartz S, Hart M, et al
Following Through: The Impact of Culinary Medicine on Mediterranean Diet Uptake in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jul 5:izae141. doi: 10.1093.
PubMed Abstract available

QIN X
Antibacterial Agents May Have Shifted Impacts on Inflammatory Bowel Diseases Along with Decrease in Gut Bacteria.
Inflamm Bowel Dis. 2024;30:1228-1231.
PubMed

OUAHED JD, Griffith A, Collen LV, Snapper SB, et al
Breaking Down Barriers: Epithelial Contributors to Monogenic IBD Pathogenesis.
Inflamm Bowel Dis. 2024;30:1189-1206.
PubMed Abstract available

LETHEN I, Lechner-Grimm K, Gabel M, Knauss A, et al
Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients.
Inflamm Bowel Dis. 2024;30:1151-1163.
PubMed Abstract available

SANTIAGO P, Quinn KP, Chen J, Friton JJ, et al
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis.
Inflamm Bowel Dis. 2024;30:1062-1070.
PubMed Abstract available

VESTERGAARD T, Kelsen J, Julsgaard M
Specialized Prenatal Care for Women With IBD Makes a Difference.
Inflamm Bowel Dis. 2024;30:1218-1219.
PubMed

LOEB L, Kinnucan J
Cannabis Use in IBD Is Associated With Increased Healthcare Utilization but not With Surgery or Death.
Inflamm Bowel Dis. 2024;30:1215-1217.
PubMed

PORTH R, Deyhim T, Zullow S, Rabinowitz LG, et al
Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab.
Inflamm Bowel Dis. 2024 Jul 2:izae140. doi: 10.1093.
PubMed Abstract available

ERTEM FU, Rivers CR, Ghaffari AA, Watson AR, et al
Efficacy of Ustekinumab and Vedolizumab Among Postoperative Crohn's Disease Patients as Postoperative Prophylaxis and Rescue Therapy: Real-world Data.
Inflamm Bowel Dis. 2024 Jul 2:izae137. doi: 10.1093.
PubMed Abstract available

June 2024

FRIEDMAN S, Thorarinsson CT, Wod M, Fedder J, et al
Paternal Inflammatory Bowel Disease and the Risk of Pregnancy Loss.
Inflamm Bowel Dis. 2024 Jun 29:izae132. doi: 10.1093.
PubMed Abstract available

NAITO T, Osaka R, Kakuta Y, Kawai Y, et al
Genetically Predicted Higher Levels of Caffeic Acid Are Protective Against Ulcerative Colitis: A Comprehensive Metabolome Analysis.
Inflamm Bowel Dis. 2024 Jun 29:izae143. doi: 10.1093.
PubMed Abstract available

TIMMER A, Neuser J, de Sordi D, Schmidt-Lauber M, et al
Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their Physicians.
Inflamm Bowel Dis. 2024 Jun 29:izae127. doi: 10.1093.
PubMed Abstract available

DOHERTY J, Ryan AW, Quinn E, Conroy J, et al
HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jun 27:izae138. doi: 10.1093.
PubMed Abstract available

RUSHER A, Araka E, Ananthakrishnan AN, Ritchie C, et al
IBD Is Like a Tree: Reflections From Older Adults With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jun 27:izae139. doi: 10.1093.
PubMed Abstract available

WHITE B, Svolos V, Gervais L, Jatkowska A, et al
Inflammation-related Proteins Support Diagnosis of Inflammatory Bowel Disease and Are Modified by Exclusive Enteral Nutrition in Children With Crohn's Disease, Especially of Ileal Phenotype.
Inflamm Bowel Dis. 2024 Jun 26:izae107. doi: 10.1093.
PubMed Abstract available

AKIYAMA S, Ollech JE, Cohen NA, Traboulsi C, et al
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jun 25:izae106. doi: 10.1093.
PubMed Abstract available

SAFRONEEVA E, Thorne H, Gerstner O, Laoun R, et al
Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets.
Inflamm Bowel Dis. 2024 Jun 21:izae123. doi: 10.1093.
PubMed Abstract available

BERTANI L, Antonioli L, Fornili M, D'Antongiovanni V, et al
Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study.
Inflamm Bowel Dis. 2024 Jun 12:izae133. doi: 10.1093.
PubMed Abstract available

HONAP S, Danese S, Peyrin-Biroulet L
Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials.
Inflamm Bowel Dis. 2024 Jun 11:izae131. doi: 10.1093.
PubMed Abstract available

BROCHARD C, Siproudhis L, Fathallah N, Zerbib P, et al
Allogenic Stem Cells in Anal Fistulas of Crohn's Disease: From Promising Premises to Real Life Experience.
Inflamm Bowel Dis. 2024 Jun 11:izae065. doi: 10.1093.
PubMed Abstract available

BURISCH J, Hart A, Sturm A, Rudolph C, et al
Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey.
Inflamm Bowel Dis. 2024 Jun 7:izae119. doi: 10.1093.
PubMed Abstract available

JOSEPH A, Bachour SP, Shah R, El Halabi J, et al
Postoperative Crohn's Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic Resection.
Inflamm Bowel Dis. 2024 Jun 6:izae117. doi: 10.1093.
PubMed Abstract available

EISENSTEIN S
Surgery in Crohn's Disease: Past Performance Does Predict Future Results.
Inflamm Bowel Dis. 2024 Jun 6:izae110. doi: 10.1093.
PubMed

DAVIES JM, Teh JJ, Ewais T, Begun J, et al
Does Improving Depression Symptoms in Young Adults With Inflammatory Bowel Disease Alter Their Microbiome?
Inflamm Bowel Dis. 2024 Jun 5:izae121. doi: 10.1093.
PubMed Abstract available

FALLOON K, Dossaji Z, Mude P, Abushamma S, et al
Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review.
Inflamm Bowel Dis. 2024 Jun 5:izae114. doi: 10.1093.
PubMed Abstract available

NIELSEN KR, Lophaven SN, Midjord J, Langholz E, et al
Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020.
Inflamm Bowel Dis. 2024 Jun 3:izae120. doi: 10.1093.
PubMed Abstract available

LEDDER O, Dolinger M, Dubinsky MC, Stein R, et al
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience.
Inflamm Bowel Dis. 2024 Jun 3:izae112. doi: 10.1093.
PubMed Abstract available

CHEN M, Wei S, Wu X, Xiang Z, et al
2'-Hydroxycinnamaldehyde Alleviates Intestinal Inflammation by Attenuating Intestinal Mucosal Barrier Damage Via Directly Inhibiting STAT3.
Inflamm Bowel Dis. 2024;30:992-1008.
PubMed Abstract available

ABOUBAKR A, Lukin DJ
Freeing Time and Reducing Costs: The Value of a Specialized Nursing Service in IBD.
Inflamm Bowel Dis. 2024;30:1046-1047.
PubMed

WITTEK A, Steglich B, Casar C, Seiz O, et al
A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
Inflamm Bowel Dis. 2024;30:900-910.
PubMed Abstract available

Correction to: Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study.
Inflamm Bowel Dis. 2024 Jun 1:izae134. doi: 10.1093.
PubMed

May 2024

KAYAL M, Barnes EL, Schwartzberg DM
The Pouch Corner: A Review of Functional Pouch Disorders.
Inflamm Bowel Dis. 2024 May 29:izae118. doi: 10.1093.
PubMed

FANSIWALA K, Spartz EJ, Roney AR, Kwaan MR, et al
Increasing Rates of Bowel Resection Surgery for Stricturing Crohn's Disease in the Biologic Era.
Inflamm Bowel Dis. 2024 May 25:izae113. doi: 10.1093.
PubMed Abstract available

KENNEDY AM, Griffiths AM, Muise AM, Walters TD, et al
Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2024 May 24:izae109. doi: 10.1093.
PubMed Abstract available

LIMKETKAI BN, Godoy-Brewer G, Shah ND, Maas L, et al
Prebiotics for Induction and Maintenance of Remission in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024 May 23:izae115. doi: 10.1093.
PubMed Abstract available

SYED S, Boland BS, Bourke LT, Chen LA, et al
Challenges in IBD Research 2024: Precision Medicine.
Inflamm Bowel Dis. 2024;30.
PubMed Abstract available

CIORBA MA, Konnikova L, Hirota SA, Lucchetta EM, et al
Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms.
Inflamm Bowel Dis. 2024;30.
PubMed Abstract available

HELLER C, Moss AC, Rubin DT
Overview to Challenges in IBD 2024-2029.
Inflamm Bowel Dis. 2024;30.
PubMed Abstract available

PRASAD S, Cross RK, Monroe MB, Dolinger MT, et al
Challenges in IBD Research 2024: Novel Technologies.
Inflamm Bowel Dis. 2024;30.
PubMed Abstract available

ANANTHAKRISHNAN AN, Gerasimidis K, Ho SM, Mayer E, et al
Challenges in IBD Research 2024: Environmental Triggers.
Inflamm Bowel Dis. 2024;30.
PubMed Abstract available

ALLEGRETTI JR, Bordeianou LG, Damas OM, Eisenstein S, et al
Challenges in IBD Research 2024: Pragmatic Clinical Research.
Inflamm Bowel Dis. 2024;30.
PubMed Abstract available

OUBOTER LF, Lindelauf C, Jiang Q, Schreurs M, et al
Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas.
Inflamm Bowel Dis. 2024 May 22:izae103. doi: 10.1093.
PubMed Abstract available

DANG N, Kumar S, Kwon M, Cradeur M, et al
Predictive Factors of Inactive Patient Participation in an Inflammatory Bowel Disease Learning Health System: A Longitudinal Cohort Study.
Inflamm Bowel Dis. 2024 May 22:izae099. doi: 10.1093.
PubMed

ATIA O, Buchuk R, Lujan R, Greenfeld S, et al
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN.
Inflamm Bowel Dis. 2024 May 20:izae094. doi: 10.1093.
PubMed Abstract available

YIN J, El-Najjar Y, Cordova N, Touma MJ, et al
Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 May 20:izae105. doi: 10.1093.
PubMed

THOMAS DM, Mundhra SK, Prasad S, Swaroop S, et al
Combined or High Dose Immunosuppression in Inflammatory Bowel Disease patients who are NUDT15 Homozygous Harbors Risk of Developing Invasive Fungal Infections: A Case Series.
Inflamm Bowel Dis. 2024 May 17:izae104. doi: 10.1093.
PubMed

BOHRA A, Van Langenberg DR
Authors' Response to Letter to Editor: "Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status".
Inflamm Bowel Dis. 2024 May 14:izae108. doi: 10.1093.
PubMed

DILLMAN JR, Tkach JA, Fletcher JG, Bruining DH, et al
MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's Disease.
Inflamm Bowel Dis. 2024 May 13:izae101. doi: 10.1093.
PubMed Abstract available

ISHIKAWA D, Zhang X, Nomura K, Shibuya T, et al
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis.
Inflamm Bowel Dis. 2024 May 11:izae080. doi: 10.1093.
PubMed Abstract available

CHOI J, Wang Q, Beaton M, Kim RB, et al
Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission.
Inflamm Bowel Dis. 2024 May 8:izae097. doi: 10.1093.
PubMed Abstract available

BOURGONJE AR, Geertsema S, Holstein HJ, Bulthuis MLC, et al
Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status.
Inflamm Bowel Dis. 2024 May 4:izae102. doi: 10.1093.
PubMed

VERNON-ROBERTS A, Chan P, Christensen B, Havrlant R, et al
Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand.
Inflamm Bowel Dis. 2024 May 3:izae087. doi: 10.1093.
PubMed Abstract available

QIAN XX
The Association of Extra-oral Halitosis With Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 May 2:izae056. doi: 10.1093.
PubMed

YANG C, Merlin D
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model.
Inflamm Bowel Dis. 2024;30:844-853.
PubMed Abstract available

SCHWARTZBERG DM, Kayal M, Barnes EL
The Ileal Pouch-Anal Anastomosis: Identifying Structural Disorders.
Inflamm Bowel Dis. 2024;30:863-867.
PubMed

COOK L, Wong MQ, Rees WD, Schick A, et al
Dysregulated Immunity to Clostridioides difficile in IBD Patients Without a History of Recognized Infection.
Inflamm Bowel Dis. 2024;30:820-828.
PubMed Abstract available

BODEN EK, Kongala R, Hindmarch DC, Shows DM, et al
Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells.
Inflamm Bowel Dis. 2024;30:704-717.
PubMed Abstract available

LIMKETKAI BN, Maas L, Krishna M, Dua A, et al
Machine Learning-based Characterization of Longitudinal Health Care Utilization Among Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2024;30:697-703.
PubMed Abstract available

April 2024

Correction to: Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Inflamm Bowel Dis. 2024 Apr 27:izae096. doi: 10.1093.
PubMed

WANG Y, Pan CW, Huang Y, Zheng X, et al
Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019.
Inflamm Bowel Dis. 2024 Apr 27:izae093. doi: 10.1093.
PubMed Abstract available

KHANNA R, Feagan BG, Zou G, Stitt LW, et al
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease.
Inflamm Bowel Dis. 2024 Apr 25:izae089. doi: 10.1093.
PubMed Abstract available

CHIN S, Fox L, Majumdar A, Oliver M, et al
Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report.
Inflamm Bowel Dis. 2024 Apr 24:izae091. doi: 10.1093.
PubMed

FUKUDA T, Aoki Y, Kiyohara H, Yokoyama A, et al
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
Inflamm Bowel Dis. 2024 Apr 24:izae088. doi: 10.1093.
PubMed Abstract available

KRUIS W, Bokemeyer B, Jessen P, Hoesl M, et al
Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS Study.
Inflamm Bowel Dis. 2024 Apr 22:izae086. doi: 10.1093.
PubMed Abstract available

DESAI A, Khataniar H, Hashash JG, Farraye FA, et al
Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity.
Inflamm Bowel Dis. 2024 Apr 20:izae090. doi: 10.1093.
PubMed Abstract available

AL RADI ZMA, Prins FM, Collij V, Vich Vila A, et al
Exploring the Predictive Value of Gut Microbiome Signatures for Therapy Intensification in Patients With Inflammatory Bowel Disease: A 10-Year Follow-up Study.
Inflamm Bowel Dis. 2024 Apr 18:izae064. doi: 10.1093.
PubMed Abstract available

HAWKINS RL, Zia M, Hind D, Lobo AJ, et al
Inequalities in Healthcare Access, Experience and Outcomes in Adults With Inflammatory Bowel Disease: A Scoping Review.
Inflamm Bowel Dis. 2024 Apr 11:izae077. doi: 10.1093.
PubMed Abstract available

INNOCENTI T, Dragoni G
Bowel Damage and Disability in Crohn's Disease: Is it Really Two Birds with One Stone?
Inflamm Bowel Dis. 2024 Apr 10:izae050. doi: 10.1093.
PubMed

CARTIER L, Loiez A, Nachury M, Azahaf M, et al
Changes Over Time in the Lemann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn's Disease.
Inflamm Bowel Dis. 2024 Apr 10:izae073. doi: 10.1093.
PubMed Abstract available

ROWAN C, Yeaman F, Ernest-Suarez K, Martin ML, et al
Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.
Inflamm Bowel Dis. 2024 Apr 9:izae076. doi: 10.1093.
PubMed

IWAMA I, Yoshida M, Miyazawa A, Hara T, et al
Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Apr 8:izae078. doi: 10.1093.
PubMed

KAYALI S, Fantasia S, Gaiani F, Cavallaro LG, et al
NOD2 and Crohn's Disease Clinical Practice: From Epidemiology to Diagnosis and Therapy, Rewired.
Inflamm Bowel Dis. 2024 Apr 6:izae075. doi: 10.1093.
PubMed Abstract available

DRYGIANNAKIS I, Kolios G, Filidou E, Bamias G, et al
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Apr 6:izae066. doi: 10.1093.
PubMed Abstract available

ATIA O, Friss C, Focht G, Magen Rimon R, et al
Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.
Inflamm Bowel Dis. 2024 Apr 5:izae067. doi: 10.1093.
PubMed Abstract available

ZAMANI M, Malekzadeh R
Reply: On the Risk of Neurological Disorders in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Apr 3:izae079. doi: 10.1093.
PubMed

LEITAO AMF, Gondim FAA
On the Risk of Neurological Disorders in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Apr 3:izae074. doi: 10.1093.
PubMed

LIN ZH, Li CP, Sun CK, Cho DY, et al
Increased Risk of Inflammatory Bowel Disease Among Patients With Nontyphoidal Salmonella Infections: A Population-Based Cohort Study.
Inflamm Bowel Dis. 2024 Apr 3:izae053. doi: 10.1093.
PubMed Abstract available

MAEDA K, Kawashima H
Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance.
Inflamm Bowel Dis. 2024;30:695-696.
PubMed

BAJAJ A, Markandey M, Singh M, Sahu P, et al
Exclusive Enteral Nutrition Mediates Beneficial Gut Microbiome Enrichment in Acute Severe Colitis.
Inflamm Bowel Dis. 2024;30:641-650.
PubMed Abstract available

KHALAJI A, Babajani N, Amirsardari Z, Saeedian B, et al
Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility.
Inflamm Bowel Dis. 2024;30:629-640.
PubMed Abstract available

PIOVANI D, Armuzzi A, Bonovas S
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024;30:573-584.
PubMed Abstract available

MARK-CHRISTENSEN A, Kristiansen EB, Laurberg S, Erichsen R, et al
Prior Appendectomy Is Associated With a Milder Clinical Course in Crohn's Disease: A Nationwide Population-based Cohort Study.
Inflamm Bowel Dis. 2024 Apr 2:izae059. doi: 10.1093.
PubMed Abstract available

UMAR N, Harvey P, Adderley NJ, Haroon S, et al
The Time to Inflammatory Bowel Disease Diagnosis for Patients Presenting with Abdominal Symptoms in Primary Care and its Association with Emergency Hospital Admissions and Surgery: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2024 Apr 2:izae057. doi: 10.1093.
PubMed Abstract available

March 2024

COLMAN RJ, Solitano V, MacDonald JK, Ma C, et al
Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review.
Inflamm Bowel Dis. 2024 Mar 28:izae060. doi: 10.1093.
PubMed Abstract available

HASHASH JG, Yu Ci Ng F, Farraye FA, Wang Y, et al
Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024 Mar 28:izae051. doi: 10.1093.
PubMed Abstract available

BERNSTEIN CN, Panaccione R, Nugent Z, Marshall DA, et al
Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study.
Inflamm Bowel Dis. 2024 Mar 27:izae055. doi: 10.1093.
PubMed Abstract available

BOHRA A, Batt N, Dutt K, Sluka P, et al
Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?
Inflamm Bowel Dis. 2024 Mar 27:izae069. doi: 10.1093.
PubMed Abstract available

YARUR AJ, Ungaro R, Huang K, Wang W, et al
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium.
Inflamm Bowel Dis. 2024 Mar 26:izae058. doi: 10.1093.
PubMed Abstract available

OLIVA S, Veraldi S, Russo G, Aloi M, et al
Pan-enteric Capsule Endoscopy to Characterize Crohn's Disease Phenotypes and Predict Clinical Outcomes in Children and Adults: The Bomiro Study.
Inflamm Bowel Dis. 2024 Mar 26:izae052. doi: 10.1093.
PubMed Abstract available

POSNER H, Lombard R, Akiyama S, Cohen NA, et al
Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post-Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Mar 23:izae029. doi: 10.1093.
PubMed Abstract available

SHAHUB S, Kumar RM, Lin KC, Banga I, et al
Continuous Monitoring of CRP, IL-6, and Calprotectin in Inflammatory Bowel Disease Using a Perspiration-Based Wearable Device.
Inflamm Bowel Dis. 2024 Mar 23:izae054. doi: 10.1093.
PubMed Abstract available

GARCIA-MATEO S, Martinez-Dominguez SJ, Gargallo-Puyuelo CJ, Gallego B, et al
Healthy Lifestyle Is a Protective Factor from Moderate and Severe Relapses and Steroid Use in Inflammatory Bowel Disease: A Prospective Cohort Study.
Inflamm Bowel Dis. 2024 Mar 23:izae062. doi: 10.1093.
PubMed Abstract available

BASTON-REY I, Rodriguez-Lago I, Luque AM, Caballol B, et al
The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU.
Inflamm Bowel Dis. 2024 Mar 22:izae041. doi: 10.1093.
PubMed Abstract available

JAIRATH V, Hunter Gibble T, Potts Bleakman A, Chatterton K, et al
Patient Perspectives of Bowel Urgency and Bowel Urgency-Related Accidents in Ulcerative Colitis and Crohn's Disease.
Inflamm Bowel Dis. 2024 Mar 21:izae044. doi: 10.1093.
PubMed Abstract available

JOLVING LR, Zegers FD, Lund K, Wod M, et al
Children and Adolescents Diagnosed With Inflammatory Bowel Disease Are at Increased Risk of Developing Diseases With a Possible Autoimmune Pathogenesis.
Inflamm Bowel Dis. 2024 Mar 20:izae047. doi: 10.1093.
PubMed Abstract available

FIORINO G, Bent-Ennakhil N, Varriale P, Braegger F, et al
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.
Inflamm Bowel Dis. 2024 Mar 20:izae015. doi: 10.1093.
PubMed Abstract available

Correction to: Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
Inflamm Bowel Dis. 2024 Mar 14:izae070. doi: 10.1093.
PubMed

ALSOUD D, Van Calster B
Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Mar 9:izae048. doi: 10.1093.
PubMed

SANDS BE, D'Haens G, Clemow DB, Irving PM, et al
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Inflamm Bowel Dis. 2024 Mar 9:izae024. doi: 10.1093.
PubMed Abstract available

FAMUTIMI D, Alayo QA, Deepak P
Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Mar 8:izae049. doi: 10.1093.
PubMed

PILLAY L, Subramanian S
The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Mar 7:izae025. doi: 10.1093.
PubMed

GEERTSEMA S, Fagundes RR, Otten AT, Dijkstra G, et al
Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.
Inflamm Bowel Dis. 2024 Mar 5:izae042. doi: 10.1093.
PubMed

HOXHA T, Youssef M, Huang V, Tandon P, et al
Inflammatory Bowel Disease and Breastfeeding: A Narrative Review.
Inflamm Bowel Dis. 2024 Mar 4:izae033. doi: 10.1093.
PubMed Abstract available

OURANOS K, Saleem H, Vassilopoulos S, Vassilopoulos A, et al
Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2024 Mar 1:izae031. doi: 10.1093.
PubMed Abstract available

GREYWOODE R, Nahvi S, Ullman T, Keefer L, et al
Feasibility and Acceptability of Digital Behavioral Interventions Among Black and Hispanic Patients With Inflammatory Bowel Disease: A Randomized Pilot Study.
Inflamm Bowel Dis. 2024 Mar 1:izae034. doi: 10.1093.
PubMed

D'AMICO F, Peyrin-Biroulet L, Danese S
Disease Clearance is not Synonymous with Cure.
Inflamm Bowel Dis. 2024;30:509.
PubMed

HESAMPOUR F, Bernstein CN, Ghia JE
Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches.
Inflamm Bowel Dis. 2024;30:482-495.
PubMed Abstract available

TSE CS, Hunt MG, Brown LA, Lewis JD, et al
Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions.
Inflamm Bowel Dis. 2024;30:501-507.
PubMed Abstract available

GEESALA R, Zhang K, Lin YM, Johnson JC, et al
Exclusive Enteral Nutrition Alleviates Th17-Mediated Inflammation via Eliminating Mechanical Stress-Induced Th17-Polarizing Cytokines in Crohn's-like Colitis.
Inflamm Bowel Dis. 2024;30:429-440.
PubMed Abstract available

February 2024

SWAMINATHAN A, Borichevsky GM, Frampton CM, Day AS, et al
Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Feb 28:izae032. doi: 10.1093.
PubMed Abstract available

GONG T, Brew BK, Lundholm C, Smew AI, et al
Comorbidity Between Inflammatory Bowel Disease and Asthma and Allergic Diseases: A Genetically Informed Study.
Inflamm Bowel Dis. 2024 Feb 27:izae027. doi: 10.1093.
PubMed Abstract available

DALAL RS, Winter RW, Gupta S, Sasson GF, et al
Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States.
Inflamm Bowel Dis. 2024 Feb 26:izae038. doi: 10.1093.
PubMed

QING X, Zhang C, Zhong Z, Zhang T, et al
Causal Association Analysis of Periodontitis and Inflammatory Bowel Disease: A Bidirectional Mendelian Randomization Study.
Inflamm Bowel Dis. 2024 Feb 26:izad188. doi: 10.1093.
PubMed Abstract available

MARTINELLI M, Miele E, Staiano A
Surgical Complications Need to Be Carefully Excluded Before Ruling Out a Diagnosis of De Novo Crohn's Disease.
Inflamm Bowel Dis. 2024 Feb 24:izae026. doi: 10.1093.
PubMed

DE JONG D, Reijntjes M, Buskens C, Hompes R, et al
Response to "De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN".
Inflamm Bowel Dis. 2024 Feb 22:izae021. doi: 10.1093.
PubMed

GREEN Z, Ashton JJ, Rodrigues A, Spray C, et al
Sustained Increase in Pediatric Inflammatory Bowel Disease Incidence Across the South West United Kingdom Over the Last 10 Years.
Inflamm Bowel Dis. 2024 Feb 19:izad302. doi: 10.1093.
PubMed Abstract available

FAN X, Liu Y, He Z, Bai Y, et al
Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study.
Inflamm Bowel Dis. 2024 Feb 16:izae019. doi: 10.1093.
PubMed

KUENZIG ME, Bitton A, Carroll MW, Otley AR, et al
Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study.
Inflamm Bowel Dis. 2024 Feb 16:izae010. doi: 10.1093.
PubMed Abstract available

URRETE J, Mitra T, Boland BS, Bertrand K, et al
Vedolizumab Does Not Affect Antibody Secreting Cell Recruitment to the Lactating Mammary Gland of Mothers With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Feb 9:izae023. doi: 10.1093.
PubMed

ATIA O, Lujan R, Buchuk R, Greenfeld S, et al
Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRN.
Inflamm Bowel Dis. 2024 Feb 8:izae014. doi: 10.1093.
PubMed Abstract available

PRENTICE R, Flanagan E, Wright E, Hardikar W, et al
Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero.
Inflamm Bowel Dis. 2024 Feb 8:izae008. doi: 10.1093.
PubMed Abstract available

SUTTICHAIMONGKOL T, Coelho-Prabhu N, Bruining DH, Tariq R, et al
Diagnostic Performance of a Fecal Calprotectin Assay as a Biomarker for Mayo Endoscopic Subscore in Ulcerative Colitis: Result From a Tertiary Referral Center.
Inflamm Bowel Dis. 2024 Feb 3:izae005. doi: 10.1093.
PubMed Abstract available

WANG C, Yang F, Qiao L, Wang X, et al
Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study.
Inflamm Bowel Dis. 2024 Feb 3:izae006. doi: 10.1093.
PubMed Abstract available

SKEJO C, Thim S, Sellmer A, Julsgaard M, et al
Early Onset Sepsis and Lobar Pneumonia in a Newborn Exposed In Utero to Ustekinumab and Azathioprine.
Inflamm Bowel Dis. 2024;30:314-315.
PubMed

SHI Y, Ullah S, Liu BR
Think Again Before Resecting an Organ: Appendectomy or Endoscopic Retrograde Appendicitis Therapy?
Inflamm Bowel Dis. 2024;30:320-321.
PubMed

WANG Z, Dreesen E
Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle.
Inflamm Bowel Dis. 2024;30:316-317.
PubMed

VESTERGAARD T, Rosok J, Julsgaard M, Bek Helmig R, et al
Time to Diagnosis and Birth Outcomes of Pregnancy-onset IBD.
Inflamm Bowel Dis. 2024;30:222-229.
PubMed Abstract available

POWERS JC, Cohen BL, Rieder F, Click BH, et al
Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases.
Inflamm Bowel Dis. 2024;30:203-212.
PubMed Abstract available

DARLINGTON K, Wang A, Herfarth HH, Barnes EL, et al
The Safety of Dilation of Ileoanal Strictures With Mechanical or Balloon Dilation Is Similar Among Patients After Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2024;30:196-202.
PubMed Abstract available

January 2024

BRIGGS K, Tomar V, Ollberding N, Haberman Y, et al
Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism.
Inflamm Bowel Dis. 2024 Jan 30:izae003. doi: 10.1093.
PubMed Abstract available

ZAMANI M, Ebrahimtabar F, Alizadeh-Tabari S, Kasner SE, et al
Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2024 Jan 25:izae012. doi: 10.1093.
PubMed Abstract available

D'HAENS G, Higgins PDR, Peyrin-Biroulet L, Sands BE, et al
Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials.
Inflamm Bowel Dis. 2024 Jan 25:izae004. doi: 10.1093.
PubMed Abstract available

NAMBU R, Miyazawa A, Yoshida M, Hara T, et al
Long-term Efficacy and Safety of Tacrolimus Plus Ustekinumab Combination Therapy in Children With Steroid-refractory Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Jan 24:izae013. doi: 10.1093.
PubMed

DUBINSKY MC, Charles L, Selmaj KW, Comi G, et al
Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis.
Inflamm Bowel Dis. 2024 Jan 24:izae011. doi: 10.1093.
PubMed

KRASNOVSKY L, Weber AT, Gershuni V, Pettke E, et al
Preoperative Exclusive Enteral Nutrition Is Associated With Reduced Skin and Soft Tissue and Intra-abdominal Infections in Patients With Crohn's Disease Undergoing Intestinal Surgery: Results from a Meta-Analysis.
Inflamm Bowel Dis. 2024 Jan 23:izad304. doi: 10.1093.
PubMed Abstract available

KATSOUDAS N, Tavakoli P, Wu N, Shapiro A, et al
Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?
Inflamm Bowel Dis. 2024 Jan 19:izad318. doi: 10.1093.
PubMed Abstract available

ALAYO QA, Famutimi D, Ayoub M, De Las Fuentes L, et al
Performance of ASCVD Risk Prediction Models in Individuals With Inflammatory Bowel Disease: A UK Biobank Study.
Inflamm Bowel Dis. 2024 Jan 18:izae007. doi: 10.1093.
PubMed

ALSOUD D, Sabino J, Franchimont D, Cremer A, et al
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
Inflamm Bowel Dis. 2024 Jan 12:izad315. doi: 10.1093.
PubMed Abstract available

WATSON A, Karam LB, Kellermayer R
Failure Rate of Anti-Tumor Necrosis Factor alpha Biologics in Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jan 11:izad313. doi: 10.1093.
PubMed

FRETZ KM, Hunker KE, Tripp DA
The Impact of Inflammatory Bowel Disease on Intimacy: A Multimethod Examination of Patients' Sexual Lives and Associated Healthcare Experiences.
Inflamm Bowel Dis. 2024 Jan 11:izad106. doi: 10.1093.
PubMed Abstract available

COLLEN LV, Snapper SB
Response to Letter to the Editor: "Failure Rate of Antitumor Necrosis Factor Alpha Biologics in Very Early Onset Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2024 Jan 11:izad317. doi: 10.1093.
PubMed

LIU M, Zhang Y, Liu J, Xiang C, et al
Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis.
Inflamm Bowel Dis. 2024 Jan 11:izad187. doi: 10.1093.
PubMed Abstract available

ATIA O, Friss C, Focht G, Magen Rimon R, et al
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.
Inflamm Bowel Dis. 2024 Jan 8:izad301. doi: 10.1093.
PubMed Abstract available

ERFAN R, Shaker OG, Khalil MAF, Mahmoud FAM, et al
Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2024 Jan 8:izad210. doi: 10.1093.
PubMed Abstract available

KHADEMI Z, Pourreza S, Amjadifar A, Torkizadeh M, et al
Dietary Patterns and Risk of Inflammatory Bowel Disease: A Systematic Review of Observational Studies.
Inflamm Bowel Dis. 2024 Jan 5:izad297. doi: 10.1093.
PubMed Abstract available

ALVISI P, Faraci S, Scarallo L, Congiu M, et al
Major Abdominal Surgery for Pediatric Crohn's Disease in the Anti-TNF Era: 10-Year Analysis of Data From the IBD Registry of Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition.
Inflamm Bowel Dis. 2024 Jan 5:izad310. doi: 10.1093.
PubMed Abstract available

BLESL A, Wurm P, Waschina S, Grochenig HP, et al
Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter Study.
Inflamm Bowel Dis. 2024;30:9-19.
PubMed Abstract available

FU SC, Qu JY, Li LX, Yang XX, et al
Excessive Mitochondrial Fission Suppresses Mucosal Repair by Impairing Butyrate Metabolism in Colonocytes.
Inflamm Bowel Dis. 2024;30:114-124.
PubMed Abstract available

TUBAU-JUNI N, Bassaganya-Riera J, Leber AJ, Alva SS, et al
Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
Inflamm Bowel Dis. 2024;30:103-113.
PubMed Abstract available

ODUFALU FD, Sewell JL, Rudrapatna V, Somsouk M, et al
Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center.
Inflamm Bowel Dis. 2024;30:29-37.
PubMed Abstract available

GOLDOWSKY A, Singh R, Moss A
Speaker Diversity and Audience Ratings at a National Inflammatory Bowel Diseases Conference.
Inflamm Bowel Dis. 2024;30:78-82.
PubMed Abstract available

LEDDER O, Harel S, Lujan R, Friss C, et al
Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.
Inflamm Bowel Dis. 2024;30:1-8.
PubMed Abstract available

FAYE AS, Lee KE, Hudesman D, Dervieux T, et al
Older Adults With Inflammatory Bowel Disease Are at Higher Risk of Developing Antibodies to Infliximab.
Inflamm Bowel Dis. 2024 Jan 3:izad305. doi: 10.1093.
PubMed

COLMAN RJ, Vuijk SA, Mathot RAA, Van Limbergen J, et al
Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn's Disease Exhibit Similar Pharmacokinetics.
Inflamm Bowel Dis. 2024 Jan 3:izad307. doi: 10.1093.
PubMed Abstract available

December 2023

FORBES AJ, Frampton CMA, Day AS, Kaplan GG, et al
The Epidemiology of Inflammatory Bowel Disease in Oceania: A Systematic Review and Meta-Analysis of Incidence and Prevalence.
Inflamm Bowel Dis. 2023 Dec 30:izad295. doi: 10.1093.
PubMed Abstract available

TEWS HC, Schmelter F, Kandulski A, Buchler C, et al
Unique Metabolomic and Lipidomic Profile in Serum From Patients With Crohn's Disease and Ulcerative Colitis Compared With Healthy Control Individuals.
Inflamm Bowel Dis. 2023 Dec 29:izad298. doi: 10.1093.
PubMed Abstract available

DUBINSKY M, Rice A, Yarlas A, Hur P, et al
Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators.
Inflamm Bowel Dis. 2023 Dec 27:izad282. doi: 10.1093.
PubMed Abstract available

FANSIWALA K, Rusher A, Shore B, Herfarth HH, et al
Oral vs Intravenous Discharge Antibiotic Regimens in the Management of Intra-abdominal Abscesses in Penetrating Crohn's Disease.
Inflamm Bowel Dis. 2023 Dec 27:izad299. doi: 10.1093.
PubMed Abstract available

ANIRVAN P, Giri S
Tofacitinib in Ulcerative Colitis: Beyond Biologics?
Inflamm Bowel Dis. 2023 Dec 24:izad308. doi: 10.1093.
PubMed

DALAL RS, Allegretti JR
Reply: Tofacitinib in Ulcerative Colitis: Beyond Biologics?
Inflamm Bowel Dis. 2023 Dec 24:izad309. doi: 10.1093.
PubMed

DUNLEAVY KA, Santiago P, Forde G, Harmsen WS, et al
Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Inflamm Bowel Dis. 2023 Dec 23:izad278. doi: 10.1093.
PubMed Abstract available

LEVINE J, McKibbin J, Ham R, Cohen-Mekelburg S, et al
Use of Upadacitinib in 16 Tofacitinib-refractory Ulcerative Colitis Patients: A Single-center Case 2Series.
Inflamm Bowel Dis. 2023 Dec 23:izad279. doi: 10.1093.
PubMed

VUYYURU SK, Ma C, Sharma T, Nguyen TM, et al
Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Dec 22:izad293. doi: 10.1093.
PubMed Abstract available

SPENCER EA, Bergstein S, Dolinger M, Pittman N, et al
Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Dec 22:izad300. doi: 10.1093.
PubMed Abstract available

SWAMINATHAN A, Fulforth JM, Frampton CM, Borichevsky GM, et al
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
Inflamm Bowel Dis. 2023 Dec 22:izad294. doi: 10.1093.
PubMed Abstract available

BRADY RE, Salwen-Deremer JK, Tunnell NC, Winter MW, et al
Understanding Medication Nonadherence in Crohn's Disease Patients: A Qualitative Evaluation.
Inflamm Bowel Dis. 2023 Dec 22:izad296. doi: 10.1093.
PubMed Abstract available

CATALAN-SERRA I, Thorsvik S, Beisvag V, Bruland T, et al
Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course.
Inflamm Bowel Dis. 2023 Dec 16:izad289. doi: 10.1093.
PubMed Abstract available

ALIZADEH M, Motwani K, Siaton BC, Abutaleb A, et al
Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD.
Inflamm Bowel Dis. 2023 Dec 15:izad280. doi: 10.1093.
PubMed Abstract available

TAO S, Long X, Gong P, Yu X, et al
Phosphoproteomics Reveals Novel Insights into the Pathogenesis and Identifies New Therapeutic Kinase Targets of Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Dec 12:izad291. doi: 10.1093.
PubMed Abstract available

Correction to: Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.
Inflamm Bowel Dis. 2023;29:2014-2015.
PubMed

Inflammatory Bowel Diseases Is Moving to Online Only Publication.
Inflamm Bowel Dis. 2023;29:2006.
PubMed

BARNES EL, Kayal M, Schwartzberg DM
The Rational Use of Advanced Therapies for Inflammatory Conditions of the Pouch.
Inflamm Bowel Dis. 2023;29:2007-2009.
PubMed

CHEN X, Zhang M, Zhou F, Gu Z, et al
SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis.
Inflamm Bowel Dis. 2023;29:1929-1940.
PubMed Abstract available

PELLINO G, Garcia-Granero A
3D Imaging and Printing in Inflammatory Bowel Diseases: Limitations, Barriers, and Opportunities Toward "Haute Couture" Surgical Approaches.
Inflamm Bowel Dis. 2023;29:1999-2000.
PubMed

BARNES EL, Chang S
Shedding New Light on High-Risk Phenotypes for Pouchitis.
Inflamm Bowel Dis. 2023;29:2003-2005.
PubMed

BAJZAT D, Keri AF, Imrei M, Koi T, et al
Safety Analysis of Preoperative Anti-TNF-alpha Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023;29:1971-1980.
PubMed Abstract available

November 2023

COLOMBEL JF, Martin-Arranz MD, Brinkman B, Guan M, et al
HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug Antibodies in Ulcerative Colitis and Crohn's Disease Patients.
Inflamm Bowel Dis. 2023 Nov 29:izad273. doi: 10.1093.
PubMed

DE VOOGD FA, Bots SJ, van Wassenaer EA, de Jong M, et al
Early Intestinal Ultrasound Predicts Clinical and Endoscopic Treatment Response and Demonstrates Drug-Specific Kinetics in Moderate-to-Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Nov 27:izad274. doi: 10.1093.
PubMed Abstract available

GAO Y, Zhang B, Zhao D, Li S, et al
Automatic Segmentation and Radiomics for Identification and Activity Assessment of CTE Lesions in Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 27:izad285. doi: 10.1093.
PubMed Abstract available

TARIQ R, Dilmaghani S
Machine Learning and Radiomics: Changing the Horizon of Crohn's Disease Assessment.
Inflamm Bowel Dis. 2023 Nov 27:izad284. doi: 10.1093.
PubMed

SAYAR S, Ozturk O
A Case of Stricturing Crohn's Disease Treated With Multiple Session Balloon Dilatation and Self-Expandable Metal Stent.
Inflamm Bowel Dis. 2023 Nov 24:izad287. doi: 10.1093.
PubMed

YAN ANG Q, Plichta D, Kim S, Hyun-A Kim I, et al
Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Nov 24:izad268. doi: 10.1093.
PubMed Abstract available

DISTANTE M, Rotulo S, Ranalli M, Pedace E, et al
Clusters of Disease Activity and Early Risk Factors of Clinical Course of Pediatric Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 23:izad275. doi: 10.1093.
PubMed Abstract available

ROSHANOV PS, Khanna R
The Use of Placebo in Clinical Trials of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Nov 21:izad281. doi: 10.1093.
PubMed

SHAW VR, Byun J, Pettit RW, Hou JK, et al
An Atlas Characterizing the Shared Genetic Architecture of Inflammatory Bowel Disease with Clinical and Behavioral Traits.
Inflamm Bowel Dis. 2023 Nov 20:izad269. doi: 10.1093.
PubMed Abstract available

FERNANDES SR, Bernardo S, Saraiva S, Rita Goncalves A, et al
Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn's Disease: A Propensity Score-Matched Analysis.
Inflamm Bowel Dis. 2023 Nov 20:izad272. doi: 10.1093.
PubMed Abstract available

SIGALL BONEH R, Westoby C, Oseran I, Sarbagili-Shabat C, et al
The Crohn's Disease Exclusion Diet: A Comprehensive Review of Evidence, Implementation Strategies, Practical Guidance, and Future Directions.
Inflamm Bowel Dis. 2023 Nov 18:izad255. doi: 10.1093.
PubMed Abstract available

FIELD J, Fenton C, Zhang L, Brickman C, et al
Inflammatory Bowel Disease and the Risk of Anal Squamous Intraepithelial Lesions and Anal Cancer in Men Who Have Sex With Men.
Inflamm Bowel Dis. 2023 Nov 10:izad266. doi: 10.1093.
PubMed Abstract available

WONG SY, Colombel JF
Cancer Screening in Patients With Inflammatory Bowel Disease: Don't Forget the Anus!
Inflamm Bowel Dis. 2023 Nov 10:izad267. doi: 10.1093.
PubMed

YAMADA S, Honzawa Y, Yamamoto S, Matsuura M, et al
Single Nucleotide Polymorphisms of the MEFV Gene E148Q Are Highly Associated With Disease Phenotype in Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 10:izad259. doi: 10.1093.
PubMed Abstract available

LITTLE RD, Swaine A, Reynolds R, Gibson DJ, et al
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
Inflamm Bowel Dis. 2023 Nov 10:izad248. doi: 10.1093.
PubMed Abstract available

CHEW DCH, Khoo XH, Lee TS, Chin KY, et al
A Systematic Review on the Increasing Incidence of Inflammatory Bowel Disease in Southeast Asia: Looking Beyond the Urbanization Phenomenon.
Inflamm Bowel Dis. 2023 Nov 3:izad189. doi: 10.1093.
PubMed Abstract available

GONZALEZ CUETO E, Edmans M, Wellens J, Cadwell K, et al
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Nov 3:izad265. doi: 10.1093.
PubMed

TUBAU-JUNI N, Hontecillas R, Leber AJ, Alva SS, et al
Treating Autoimmune Diseases With LANCL2 Therapeutics: A Novel Immunoregulatory Mechanism for Patients With Ulcerative Colitis and Crohn's Disease.
Inflamm Bowel Dis. 2023 Nov 2:izad258. doi: 10.1093.
PubMed Abstract available

RUBIN DT, Torres J, Dotan I, Xu LT, et al
An Insight into Patients' Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts.
Inflamm Bowel Dis. 2023 Nov 2:izad247. doi: 10.1093.
PubMed Abstract available

FEATHERS A, Lovasi GS, Grigoryan Z, Beem K, et al
Crohn's Disease Mortality and Ambient Air Pollution in New York City.
Inflamm Bowel Dis. 2023 Nov 2:izad243. doi: 10.1093.
PubMed Abstract available

CHANG S, Hong S, Hudesman D, Remzi F, et al
Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2023;29:1769-1777.
PubMed Abstract available

LUO Y, Schmidt N, Dubinsky MC, Jaffin B, et al
Evaluating lleal Pouch Anal Anastomosis Function: Time to Expand Our ARM-amentarium.
Inflamm Bowel Dis. 2023;29:1819-1825.
PubMed Abstract available

NARDONE OM, Calabrese G, Barberio B, Giglio MC, et al
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis.
Inflamm Bowel Dis. 2023 Nov 1:izad252. doi: 10.1093.
PubMed Abstract available

October 2023

KRUGLIAK CLEVELAND N, Ghosh S, Chastek B, Bancroft T, et al
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY.
Inflamm Bowel Dis. 2023 Oct 31:izad245. doi: 10.1093.
PubMed Abstract available

GUO A, Ostensson M, Stordal K, Ludvigsson J, et al
Early-Life Hygiene-Related Factors and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
Inflamm Bowel Dis. 2023 Oct 31:izad257. doi: 10.1093.
PubMed Abstract available

RIGGOTT C, Fairbrass KM, Selinger CP, Gracie DJ, et al
Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study.
Inflamm Bowel Dis. 2023 Oct 31:izad256. doi: 10.1093.
PubMed Abstract available

Correction to: Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission.
Inflamm Bowel Dis. 2023 Oct 27:izad261. doi: 10.1093.
PubMed

FU J, Chai C, Chen L, Cai M, et al
Associations of Fish and Fish Oil Consumption With Incident Inflammatory Bowel Disease: A Population-Based Prospective Cohort Study.
Inflamm Bowel Dis. 2023 Oct 27:izad262. doi: 10.1093.
PubMed Abstract available

HUANG Z, Cheng W, Chao K, Tang J, et al
Baseline and Postinduction Intestinal Ultrasound Findings Predict Long-term Transmural and Mucosal Healing in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023 Oct 27:izad251. doi: 10.1093.
PubMed Abstract available

ASSADSANGABI A, Evans CA, Corfe BM, Lobo AJ, et al
Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach.
Inflamm Bowel Dis. 2023 Oct 27:izad241. doi: 10.1093.
PubMed Abstract available

WELLENS J, Chen J, Fu T, Zhang Y, et al
Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
Inflamm Bowel Dis. 2023 Oct 25:izad249. doi: 10.1093.
PubMed

SHEEHAN JL, Jordan AA, Newman KL, Johnson LA, et al
Are Depression and Anxiety Underdiagnosed in Socially Vulnerable Patients With Inflammatory Bowel Disease?
Inflamm Bowel Dis. 2023 Oct 25:izad246. doi: 10.1093.
PubMed Abstract available

Correction to: Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Inflamm Bowel Dis. 2023 Oct 25:izad260. doi: 10.1093.
PubMed

LUND K, Zegers FD, Nielsen J, Brodersen JB, et al
Inflammatory Bowel Disease in Adults and Elderly: The Use of Selected Non-IBD Medication Examined in a Nationwide Cohort Study.
Inflamm Bowel Dis. 2023 Oct 24:izad244. doi: 10.1093.
PubMed Abstract available

DIMOPOULOS-VERMA A, Hong S, Axelrad JE
Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years.
Inflamm Bowel Dis. 2023 Oct 20:izad253. doi: 10.1093.
PubMed Abstract available

DONNELLY M, Driever D, Ryan EJ, Elliott JA, et al
Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
Inflamm Bowel Dis. 2023 Oct 20:izad225. doi: 10.1093.
PubMed Abstract available

DAL BUONO A, Armuzzi A
Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Oct 20:izad254. doi: 10.1093.
PubMed

MASSIRONI S, Sileri P, Danese S
Get Fit: Muscle Health for Crohn's Disease Surgical Outcome Optimization.
Inflamm Bowel Dis. 2023 Oct 20:izad235. doi: 10.1093.
PubMed

PRAKASH P, Dua A, Blumenfeld Y, Chen PH, et al
Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis.
Inflamm Bowel Dis. 2023 Oct 19:izad250. doi: 10.1093.
PubMed Abstract available

HEYDARI R, Fayazzadeh S, Shahrokh S, Shekari F, et al
Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023 Oct 19:izad219. doi: 10.1093.
PubMed Abstract available

COLLEN LV, Mitsialis V, Kim DY, Bresnahan M, et al
Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Oct 17:izad196. doi: 10.1093.
PubMed Abstract available

KRUGLIAK CLEVELAND N, Miyatani Y, Picker EA, Rubin DT, et al
At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Oct 16:izad237. doi: 10.1093.
PubMed

DALAL RS, Sharma PP, Bains K, Pruce JC, et al
Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.
Inflamm Bowel Dis. 2023 Oct 16:izad242. doi: 10.1093.
PubMed Abstract available

SCHMOYER CJ, Sun K, Zack J, Kumar P, et al
Adverse Events and Compliance Among Inflammatory Bowel Disease Patients Treated With Home- vs Office-Based Biologic Infusions.
Inflamm Bowel Dis. 2023 Oct 11:izad226. doi: 10.1093.
PubMed Abstract available

TARIQ R, Loftus EV
Home-based Biologic Infusions for Inflammatory Bowel Disease: Are We Ready for Prime Time?
Inflamm Bowel Dis. 2023 Oct 11:izad240. doi: 10.1093.
PubMed

SMITH RA, Desai A, Hashash JG, Hayney MS, et al
Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines.
Inflamm Bowel Dis. 2023 Oct 10:izad233. doi: 10.1093.
PubMed

MARTINELLI M, Romeo E, Caldaro T, Dimakou K, et al
De Novo Crohn's Disease in Children With Ulcerative Colitis Undergoing Ileal Pouch-Anal Anastomosis: A Multicenter, Retrospective Study From the Pediatric IBD Porto Group of the ESPGHAN.
Inflamm Bowel Dis. 2023 Oct 10:izad199. doi: 10.1093.
PubMed Abstract available

O'SHEA D, Picoraro JA
De Novo Crohn's Disease in the Pediatric Pouch.
Inflamm Bowel Dis. 2023 Oct 10:izad231. doi: 10.1093.
PubMed Abstract available

KLEEBAYOON A, Wiwanitkit V
SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Oct 10:izad230. doi: 10.1093.
PubMed

Correction to: Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
Inflamm Bowel Dis. 2023 Oct 9:izad239. doi: 10.1093.
PubMed

REIJNTJES M, de Jong D, Wessels E, Goetgebuer R, et al
Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential Overdiagnoses.
Inflamm Bowel Dis. 2023 Oct 6:izad228. doi: 10.1093.
PubMed Abstract available

RAO V, Cockburn E, Segal JP
Is Ulcerative Colitis Really Ever "Cleared?".
Inflamm Bowel Dis. 2023 Oct 5:izad234. doi: 10.1093.
PubMed

LAHEIJ RLH, van Knippenberg YMW, Heil ALJ, Mannaerts BJW, et al
The Efficacy of an Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in Patients With Inflammatory Bowel Disease in Remission With Immunomodulators and/or Biological Agents: A Randomized, Double-Blind, Placebo-Controlled Clini
Inflamm Bowel Dis. 2023 Oct 4:izad216. doi: 10.1093.
PubMed Abstract available

BISLENGHI G, Van Den Bossch J, Fieuws S, Wolthuis A, et al
Appearance of the Bowel and Mesentery During Surgery Is Not Predictive of Postoperative Recurrence After Ileocecal Resection for Crohn's Disease: A Prospective Monocentric Study.
Inflamm Bowel Dis. 2023 Oct 4:izad227. doi: 10.1093.
PubMed Abstract available

YANG W, Cong Y
Exploring Colitis through Dynamic T Cell Adoptive Transfer Models.
Inflamm Bowel Dis. 2023;29:1673-1680.
PubMed Abstract available

YIN Y, Wan J, Yu J, Wu K, et al
Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
Inflamm Bowel Dis. 2023;29:1648-1657.
PubMed Abstract available

WEIDINGER C, Siegmund B
Deciphering Cellular Networks in Creeping Fat.
Inflamm Bowel Dis. 2023;29:1670-1672.
PubMed

September 2023

TYRODE G, Lakkis Z, Vernerey D, Falcoz A, et al
KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's Disease.
Inflamm Bowel Dis. 2023 Sep 30:izad214. doi: 10.1093.
PubMed Abstract available

LEE YJ, Li D, Mujukian A, Debbas P, et al
Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Sep 29:izad198. doi: 10.1093.
PubMed

CATASSI G, D'Arcangelo G, Norsa L, Bramuzzo M, et al
Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.
Inflamm Bowel Dis. 2023 Sep 28:izad218. doi: 10.1093.
PubMed Abstract available

METWALY A, Haller D
The TNF?ARE Model of Crohn's Disease-like Ileitis.
Inflamm Bowel Dis. 2023 Sep 26:izad205. doi: 10.1093.
PubMed Abstract available

LIU GXH, Day AS
Plant-based Diets for Inflammatory Bowel Disease: What Is the Evidence?
Inflamm Bowel Dis. 2023 Sep 25:izad213. doi: 10.1093.
PubMed Abstract available

PATEL R, Marrie RA, Bernstein CN, Bolton JM, et al
Vascular Disease Is Associated With Differences in Brain Structure and Lower Cognitive Functioning in Inflammatory Bowel Disease: A Cross-Sectional Study.
Inflamm Bowel Dis. 2023 Sep 22:izad204. doi: 10.1093.
PubMed Abstract available

SIGVARDSSON I, Stordal K, Ostensson M, Guo A, et al
Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
Inflamm Bowel Dis. 2023 Sep 22:izad220. doi: 10.1093.
PubMed Abstract available

GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
Reply: "Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?".
Inflamm Bowel Dis. 2023 Sep 21:izad222. doi: 10.1093.
PubMed

ERRIDGE S, Sodergren MH
Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?
Inflamm Bowel Dis. 2023 Sep 21:izad221. doi: 10.1093.
PubMed

BARBER GE, Zhuo J, Okafor PN, Streett S, et al
Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 21:izad207. doi: 10.1093.
PubMed Abstract available

SNINSKY JA, Staicu AM, Barnes EL
In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk.
Inflamm Bowel Dis. 2023 Sep 21:izad215. doi: 10.1093.
PubMed

LASA J, Nazario E, De Sanctis G, Fernandez Recalde M, et al
Endoscopically Active Ulcerative Colitis Is Associated With Asymptomatic Atherosclerotic Vascular Disease: A Case-Control Study.
Inflamm Bowel Dis. 2023 Sep 21:izad217. doi: 10.1093.
PubMed Abstract available

LI WAI SUEN CFD, Seah D, Choy MC, De Cruz P, et al
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 19:izad183. doi: 10.1093.
PubMed Abstract available

NASEEM K, Sohail A, Quang Nguyen V, Khan A, et al
Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.
Inflamm Bowel Dis. 2023 Sep 19:izad200. doi: 10.1093.
PubMed Abstract available

SHAH S, Shillington AC, Kabagambe EK, Deering KL, et al
Racial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online Survey.
Inflamm Bowel Dis. 2023 Sep 13:izad194. doi: 10.1093.
PubMed Abstract available

GUGLIELMI G, Crucitta S, Bertani L, Ruglioni M, et al
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-alpha Biologics.
Inflamm Bowel Dis. 2023 Sep 11:izad181. doi: 10.1093.
PubMed Abstract available

DEL CHIERICO F, Cardile S, Baldelli V, Alterio T, et al
Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 11:izad203. doi: 10.1093.
PubMed Abstract available

Correction to: Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Sep 9:izad223. doi: 10.1093.
PubMed

MIYATANI Y, Micic D
Revisiting the Risk of Hospital Readmission in Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Sep 8:izad212. doi: 10.1093.
PubMed

KIM SH, Buhle A, Roberts A, Singh N, et al
Multidisciplinary Inflammatory Bowel Disease Conference: The Impact of the Expert Pathologist on Patient Care.
Inflamm Bowel Dis. 2023 Sep 6:izad192. doi: 10.1093.
PubMed Abstract available

SITKIN S, Pokrotnieks J
Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Sep 6:izad209. doi: 10.1093.
PubMed

DI MARTINO L
Reply: "Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-Modulating Therapy for Inflammatory Bowel Disease".
Inflamm Bowel Dis. 2023 Sep 6:izad206. doi: 10.1093.
PubMed

SINGH A, Midha V, Kochhar GS, Shen B, et al
Management of Perianal Fistulizing Crohn's Disease.
Inflamm Bowel Dis. 2023 Sep 6:izad195. doi: 10.1093.
PubMed Abstract available

CROUWEL F, Bayoumy AB, Mulder CJJ, Peters JHC, et al
The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Sep 2:izad197. doi: 10.1093.
PubMed Abstract available

HERRERA-DEGUISE C, Varela E, Sarrabayrouse G, Pozuelo Del Rio M, et al
Gut Microbiota Composition in Long-Remission Ulcerative Colitis is Close to a Healthy Gut Microbiota.
Inflamm Bowel Dis. 2023;29:1362-1369.
PubMed Abstract available

RUTHERFORD D, Ho GT
Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:1488-1498.
PubMed Abstract available

NORGARD BM, Zegers FD, Nielsen J, Knudsen T, et al
COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
Inflamm Bowel Dis. 2023;29:1470-1476.
PubMed Abstract available

AKIYAMA S, Cohen NA, Kayal M, Dubinsky MC, et al
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States.
Inflamm Bowel Dis. 2023;29:1504-1507.
PubMed

AINSWORTH MA
How to Minimize Placebo Response and Remission Rates.
Inflamm Bowel Dis. 2023;29:1508-1509.
PubMed

IACUCCI M, Jeffery L, Acharjee A, Grisan E, et al
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.
Inflamm Bowel Dis. 2023;29:1409-1420.
PubMed Abstract available

OUTTIER A, Gijbels L, Noman M, Verstockt B, et al
Screening Failure in a Large Clinical Trial Centre for Inflammatory Bowel Diseases: Rates, Causes, and Outcomes.
Inflamm Bowel Dis. 2023;29:1440-1445.
PubMed Abstract available

MASSIRONI S, Pirola L, Mulinacci G, Ciaccio A, et al
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
Inflamm Bowel Dis. 2023;29:1477-1487.
PubMed Abstract available

CUOMO M, Carobbio A, Aloi M, Alvisi P, et al
Induction of Remission With Exclusive Enteral Nutrition in Children With Crohn's Disease: Determinants of Higher Adherence and Response.
Inflamm Bowel Dis. 2023;29:1380-1389.
PubMed Abstract available

August 2023

LIU T, Lin CH, Chen YL, Yeh CC, et al
Relationship Between Rectal Swab and Tissue Samples in Mucosa-associated Microbiota in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 31:izad179. doi: 10.1093.
PubMed Abstract available

BHAT S, Lyu R, Agarwal M, Becker M, et al
Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus.
Inflamm Bowel Dis. 2023 Aug 31:izad143. doi: 10.1093.
PubMed Abstract available

JACOBS JP, Sauk JS, Ahdoot AI, Liang F, et al
Microbial and Metabolite Signatures of Stress Reactivity in Ulcerative Colitis Patients in Clinical Remission Predict Clinical Flare Risk.
Inflamm Bowel Dis. 2023 Aug 31:izad185. doi: 10.1093.
PubMed Abstract available

YU N, Wu K, Samyue T, Fry S, et al
Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service.
Inflamm Bowel Dis. 2023 Aug 29:izad145. doi: 10.1093.
PubMed Abstract available

TOKUSHIMA K, Jimbo K, Suzuki M, Endo Y, et al
Differentiation of Active Ulcerative Colitis vs Noninflammatory Bowel Disease Proctitis by Transperineal Superb Microvascular Imaging.
Inflamm Bowel Dis. 2023 Aug 29:izad186. doi: 10.1093.
PubMed Abstract available

REN H, Kang J, Wang J, Su J, et al
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease.
Inflamm Bowel Dis. 2023 Aug 24:izad184. doi: 10.1093.
PubMed Abstract available

MOULTON CD, Jordan C, Hayee B, Chalder T, et al
All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study.
Inflamm Bowel Dis. 2023 Aug 24:izad193. doi: 10.1093.
PubMed

DALAL RS, Sharma PP, Bains K, Pruce JC, et al
1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States.
Inflamm Bowel Dis. 2023 Aug 24:izad165. doi: 10.1093.
PubMed

WANDS DIF, Gianolio L, Wilson DC, Hansen R, et al
Nationwide Real-World Exclusive Enteral Nutrition Practice Over Time: Persistence of Use as Induction for Pediatric Crohn's Disease and Emerging Combination Strategy With Biologics.
Inflamm Bowel Dis. 2023 Aug 24:izad167. doi: 10.1093.
PubMed Abstract available

LONG MD, Parlett L, Lewis JD, Haynes K, et al
Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 23:izad176. doi: 10.1093.
PubMed Abstract available

ZINGER CH, Ringel Y, Eitan M, Openhaim M, et al
Upadacitinib for Acute Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Aug 23:izad180. doi: 10.1093.
PubMed

BROWNSON E, Saunders J, Jatkowska A, White B, et al
Micronutrient Status and Prediction of Disease Outcome in Adults With Inflammatory Bowel Disease Receiving Biologic Therapy.
Inflamm Bowel Dis. 2023 Aug 23:izad174. doi: 10.1093.
PubMed Abstract available

MARTINEZ-DOMINGUEZ SJ, Garcia-Mateo S, Gargallo-Puyuelo CJ, Gallego-Llera B, et al
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
Inflamm Bowel Dis. 2023 Aug 22:izad175. doi: 10.1093.
PubMed Abstract available

TRACY MS, Challa PK, Lopes EW, Khalili H, et al
Prevalence and Treatment Patterns of Inflammatory Bowel Disease in the All of Us Research Program.
Inflamm Bowel Dis. 2023 Aug 21:izad170. doi: 10.1093.
PubMed

COONEY R, Tang D, Barrett K, Russell RK, et al
Children and Young Adults With Inflammatory Bowel Disease Have an Increased Incidence and Risk of Developing Mental Health Conditions: A UK Population-Based Cohort Study.
Inflamm Bowel Dis. 2023 Aug 21:izad169. doi: 10.1093.
PubMed Abstract available

TRAVIS S, Potts Bleakman A, Dubinsky MC, Schreiber S, et al
The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Aug 21:izad142. doi: 10.1093.
PubMed Abstract available

D'ARCANGELO G, Russo G, Aloi M, Ruggiero C, et al
A Treat-to-Target Strategy Guided by Pan-Enteric Evaluation in Children With Crohn's Disease Improves Outcomes at 2 Years.
Inflamm Bowel Dis. 2023 Aug 21:izad173. doi: 10.1093.
PubMed Abstract available

RASMUSSEN J, Norgard BM, Nielsen RG, Boggild H, et al
Implication of Inflammatory Bowel Disease Diagnosed Before the Age of 18 for Achieving an Upper Secondary Education: A Nationwide Population-Based Cohort Study.
Inflamm Bowel Dis. 2023 Aug 21:izad157. doi: 10.1093.
PubMed Abstract available

OSHIMA N, Hiraoka S, Hayashi R, Takahashi S, et al
Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Aug 19:izad150. doi: 10.1093.
PubMed Abstract available

HANZEL J, Ma C, De Silva TA, Alphonsus L, et al
Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration.
Inflamm Bowel Dis. 2023 Aug 17:izad168. doi: 10.1093.
PubMed

GLICKMAN D, Dalessio S, Raup-Konsavage WM, Vrana KE, et al
The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.
Inflamm Bowel Dis. 2023 Aug 14:izad151. doi: 10.1093.
PubMed Abstract available

ZHU Z, Jia Y, Li FR, Li Y, et al
Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes.
Inflamm Bowel Dis. 2023 Aug 14:izad163. doi: 10.1093.
PubMed Abstract available

MUJUKIAN A, Kumar R, Li D, Debbas P, et al
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
Inflamm Bowel Dis. 2023 Aug 9:izad114. doi: 10.1093.
PubMed Abstract available

D'AMICO F, Magro F, Siegmund B, Kobayashi T, et al
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus.
Inflamm Bowel Dis. 2023 Aug 7:izad159. doi: 10.1093.
PubMed Abstract available

RESAL T, Bacsur P, Keresztes C, Balint A, et al
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study.
Inflamm Bowel Dis. 2023 Aug 5:izad135. doi: 10.1093.
PubMed Abstract available

DUBOIS KE, Blake CE, Rudisill C, Harrison SE, et al
Ulcerative Colitis Is Associated With Diet-related Inflammation and Physical Activity in the IBD Partners E-cohort.
Inflamm Bowel Dis. 2023 Aug 5:izad139. doi: 10.1093.
PubMed Abstract available

DI PETRILLO A, Kumar A, Onali S, Favale A, et al
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 5:izad161. doi: 10.1093.
PubMed Abstract available

SHEHAB M, Al Akram S, Hassan A, Alrashed F, et al
Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2023 Aug 4:izad119. doi: 10.1093.
PubMed Abstract available

DESAI A, Soni A, Hayney MS, Hashash JG, et al
Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study.
Inflamm Bowel Dis. 2023 Aug 4:izad162. doi: 10.1093.
PubMed Abstract available

WANG Q, Chen F, Peng Y, Yi X, et al
Research Progress of Interleukin-27 in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Aug 4:izad153. doi: 10.1093.
PubMed Abstract available

VIGANO C, Palermo A, Mulinacci G, Pirola L, et al
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group).
Inflamm Bowel Dis. 2023 Aug 3:izad146. doi: 10.1093.
PubMed Abstract available

ALDARS-GARCIA L, Gil-Redondo R, Embade N, Riestra S, et al
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naive Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Aug 3:izad154. doi: 10.1093.
PubMed Abstract available

ZHU N, Zhu J, Mei Q
Low-density Granulocytes as a Novel Biomarkers of Disease Activity in IBD.
Inflamm Bowel Dis. 2023;29:e31.
PubMed

XIE K, Ortiz Cerda T, Schroder A, Shiung N, et al
Response to Low-density Granulocytes as Novel Biomarkers of Disease Activity in IBD.
Inflamm Bowel Dis. 2023;29:e32.
PubMed

BAMIAS G, Kitsou K, Rivera-Nieves J
The Underappreciated Role of Secretory IgA in IBD.
Inflamm Bowel Dis. 2023;29:1327-1341.
PubMed Abstract available

ROSEIRA J, Santiago M, Estevinho MM, Moreira P, et al
Impact of Crohn's Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis.
Inflamm Bowel Dis. 2023;29:1231-1243.
PubMed Abstract available

KAMP KJ, Hawes SE, Tse CS, Singh S, et al
Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment.
Inflamm Bowel Dis. 2023;29:1255-1262.
PubMed Abstract available

PRAY C, Wong ECL, Aruljothy A, Dulai PS, et al
Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.
Inflamm Bowel Dis. 2023;29:1263-1271.
PubMed Abstract available

July 2023

CROWLEY E, Ma C, Guizzetti L, Zou G, et al
Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
Inflamm Bowel Dis. 2023 Jul 31:izad134. doi: 10.1093.
PubMed Abstract available

MARK-CHRISTENSEN A, Kristiansen EB, Myrelid P, Laurberg S, et al
Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.
Inflamm Bowel Dis. 2023 Jul 31:izad141. doi: 10.1093.
PubMed Abstract available

OTTEN AT, Dijkstra G, Visschedijk MC, Bourgonje AR, et al
The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients.
Inflamm Bowel Dis. 2023 Jul 31:izad144. doi: 10.1093.
PubMed

DALAL RS, Lund K, Zegers FD, Friedman S, et al
Use of Tramadol vs Traditional Opioids and Adverse Outcomes in Patients with Inflammatory Bowel Disease: A Danish Nationwide Cohort Study.
Inflamm Bowel Dis. 2023 Jul 31:izad156. doi: 10.1093.
PubMed Abstract available

BOKEMEYER B, Plachta-Danielzik S, di Giuseppe R, Efken P, et al
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naive Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Inflamm Bowel Dis. 2023 Jul 31:izad138. doi: 10.1093.
PubMed Abstract available

LAW CCY, Tkachuk B, Lieto S, Narula N, et al
Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2023 Jul 28:izad149. doi: 10.1093.
PubMed Abstract available

OKITA M, Nakashima K, Yamamura T, Matsui S, et al
Systematic Review and Meta-Analysis of the Use of Serum Leucine-Rich Alpha-2 Glycoprotein to Assess Crohn's Disease Activity.
Inflamm Bowel Dis. 2023 Jul 28:izad128. doi: 10.1093.
PubMed Abstract available

LEE S, Seow CH, Nerenberg K, Bertazzon S, et al
Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study.
Inflamm Bowel Dis. 2023 Jul 27:izad147. doi: 10.1093.
PubMed Abstract available

DALAL RS, Kallumkal G, Cabral HJ, Bachour S, et al
Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Jul 27:izad155. doi: 10.1093.
PubMed

MCNAMARA J, Connor SJ, Andrews JM
The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform.
Inflamm Bowel Dis. 2023 Jul 25:izad148. doi: 10.1093.
PubMed

MARAFINI I, De Cristofaro E, Salvatori S, Calabrese E, et al
Niclosamide Enema for Active Distal Ulcerative Colitis: A Phase 1, Open-Label Study.
Inflamm Bowel Dis. 2023 Jul 21:izad125. doi: 10.1093.
PubMed Abstract available

ALIZADEH M, Ali O, Cross RK
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023 Jul 21:izad131. doi: 10.1093.
PubMed Abstract available

ROMANO D, Chesterman S, Fuller-Tyszkiewicz M, Evans S, et al
Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress.
Inflamm Bowel Dis. 2023 Jul 21:izad122. doi: 10.1093.
PubMed Abstract available

PASCUAL-OLIVER A, Casas-Deza D, Cuaran C, Garcia-Lopez S, et al
HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis. 2023 Jul 18:izad130. doi: 10.1093.
PubMed Abstract available

LIU F, Xu W, Wang Y, Huang Z, et al
LAMB3 Promotes Intestinal Inflammation Through SERPINA3 and Is Directly Transcriptionally Regulated by P65 in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jul 15:izad140. doi: 10.1093.
PubMed Abstract available

MCHENRY S, Glover M, Ahmed A, Alayo Q, et al
NAFLD Is Associated With Quiescent Rather Than Active Crohn's Disease.
Inflamm Bowel Dis. 2023 Jul 15:izad129. doi: 10.1093.
PubMed Abstract available

BHAT S, Click B, Regueiro M
Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.
Inflamm Bowel Dis. 2023 Jul 14:izad120. doi: 10.1093.
PubMed Abstract available

ROOSENBOOM B, Wahab PJ, Smids C, Meijer J, et al
Mucosal alpha4beta7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Jul 12:izad123. doi: 10.1093.
PubMed Abstract available

KOGAN L, Townsend MJ, Raj D, Levy AN, et al
Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2023 Jul 8:izad121. doi: 10.1093.
PubMed

ZENG Z, Cheng S, Li X, Liu H, et al
Glycolytic Activation of CD14+ Intestinal Macrophages Contributes to the Inflammatory Responses via Exosomal Membrane Tumor Necrosis Factor in Crohn's Disease.
Inflamm Bowel Dis. 2023 Jul 5:izad117. doi: 10.1093.
PubMed Abstract available

DAI C, Huang YH
Frail Phenotype in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023;29:e30.
PubMed

RAUSCH P, Ellul S, Pisani A, Bang C, et al
Microbial Dynamics in Newly Diagnosed and Treatment Naive IBD Patients in the Mediterranean.
Inflamm Bowel Dis. 2023;29:1118-1132.
PubMed Abstract available

GARCIA-HERNANDEZ V, Raya-Sandino A, Azcutia V, Miranda J, et al
Inhibition of Soluble Stem Cell Factor Promotes Intestinal Mucosal Repair.
Inflamm Bowel Dis. 2023;29:1133-1144.
PubMed Abstract available

LAM GA, Albarrak H, McColl CJ, Pizarro A, et al
The Oral-Gut Axis: Periodontal Diseases and Gastrointestinal Disorders.
Inflamm Bowel Dis. 2023;29:1153-1164.
PubMed Abstract available

ADLER J, Colletti RB, Noonan L, Berzin TM, et al
Validating the Simplified Endoscopic Mucosal Assessment for Crohn's Disease: A Novel Method for Assessing Disease Activity.
Inflamm Bowel Dis. 2023;29:1089-1097.
PubMed Abstract available

SIGURDSSON GV, Schmidt S, Mellstrom D, Ohlsson C, et al
Young Adult Male Patients With Childhood-onset IBD Have Increased Risks of Compromised Cortical and Trabecular Bone Microstructures.
Inflamm Bowel Dis. 2023;29:1065-1072.
PubMed Abstract available

WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naive Crohn's Disease.
Inflamm Bowel Dis. 2023;29:1015-1023.
PubMed Abstract available

PROIETTI E, Pauwels RWM, van der Woude CJ, Doukas M, et al
Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction.
Inflamm Bowel Dis. 2023;29:1038-1046.
PubMed Abstract available

CHANDAN S, Dhindsa BS, Khan SR, Deliwala S, et al
Endoscopic Stenting in Crohn's Disease-related Strictures: A Systematic Review and Meta-analysis of Outcomes.
Inflamm Bowel Dis. 2023;29:1145-1152.
PubMed Abstract available

June 2023

MACALUSO FS, Principi M, Facciotti F, Contaldo A, et al
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study.
Inflamm Bowel Dis. 2023 Jun 30:izad118. doi: 10.1093.
PubMed

ADIMADHYAM S, Lewis JD, Simon AL, Wolfe AE, et al
Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Jun 26:izad115. doi: 10.1093.
PubMed Abstract available

WONG SY, Wellens J, Helmus D, Marlow L, et al
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
Inflamm Bowel Dis. 2023 Jun 24:izad097. doi: 10.1093.
PubMed Abstract available

ITO N, Kudo T, Eguchi H, Jimbo K, et al
Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jun 16:izad116. doi: 10.1093.
PubMed Abstract available

TE GROEN M, Derikx LAAP, van Lierop L, Ylstra B, et al
Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study.
Inflamm Bowel Dis. 2023 Jun 16:izad112. doi: 10.1093.
PubMed

MULES TC, Lavender B, Maclean K, Vacca F, et al
Controlled Hookworm Infection for Medication-free Maintenance in Patients with Ulcerative Colitis: A Pilot, Double-blind, Randomized Control Trial.
Inflamm Bowel Dis. 2023 Jun 15:izad110. doi: 10.1093.
PubMed Abstract available

SEHGAL P, Su S, Zech J, Nobel Y, et al
Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Inflamm Bowel Dis. 2023 Jun 12:izad111. doi: 10.1093.
PubMed Abstract available

TANEJA V, Anand RS, El-Dallal M, Dong J, et al
Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients: Systematic Review and Meta-Analysis.
Inflamm Bowel Dis. 2023 Jun 10:izad108. doi: 10.1093.
PubMed Abstract available

ODUFALU FD, Dubinsky MC, Peyrin-Biroulet L, Ylanne K, et al
Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.
Inflamm Bowel Dis. 2023 Jun 10:izad102. doi: 10.1093.
PubMed Abstract available

RHUDY CN, Perry CL, Hawk GS, Flomenhoft DR, et al
Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization.
Inflamm Bowel Dis. 2023 Jun 6:izad096. doi: 10.1093.
PubMed Abstract available

SCALDAFERRI F, D'Onofrio AM, Calia R, Di Vincenzo F, et al
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center.
Inflamm Bowel Dis. 2023 Jun 6:izad091. doi: 10.1093.
PubMed Abstract available

SUTTICHAIMONGKOL T, Loftus EV
Characteristics, Clinical Outcomes, and Prognosis of Anal and Pouch-related Carcinoma in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023 Jun 6:izad104. doi: 10.1093.
PubMed Abstract available

SARTER H, Savoye G, Marot G, Ley D, et al
A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study.
Inflamm Bowel Dis. 2023 Jun 2:izad090. doi: 10.1093.
PubMed Abstract available

OTTEN AT, van der Meulen HH, Steenhuis M, Loeff FC, et al
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jun 2:izad103. doi: 10.1093.
PubMed Abstract available

LIGHTNER AL, Otero-Pineiro A, Reese J, Ream J, et al
A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Inflamm Bowel Dis. 2023 Jun 1:izad100. doi: 10.1093.
PubMed Abstract available

CARPINETI C, Mugheddu C, Cadoni M, Anedda J, et al
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab.
Inflamm Bowel Dis. 2023 Jun 1:izad107. doi: 10.1093.
PubMed

KHROM M, Li D, Naito T, Lee HS, et al
Sex-Dimorphic Analyses Identify Novel and Sex-Specific Genetic Associations in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Jun 1:izad089. doi: 10.1093.
PubMed Abstract available

EL HAJJ W, Buisson A, Olympie A, Ravel MH, et al
Impact of Inflammatory Bowel Disease on Patients' Caregivers: Results From a French Survey.
Inflamm Bowel Dis. 2023 Jun 1:izad093. doi: 10.1093.
PubMed Abstract available

TSOUNIS EP, Aggeletopoulou I, Mouzaki A, Triantos C, et al
Creeping Fat in the Pathogenesis of Crohn's Disease: An Orchestrator or a Silent Bystander?
Inflamm Bowel Dis. 2023 Jun 1:izad095. doi: 10.1093.
PubMed Abstract available

HONG SN, Song JH, Kim SJ, Park YH, et al
One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study.
Inflamm Bowel Dis. 2023 Jun 1:izad094. doi: 10.1093.
PubMed Abstract available

KARIME C, Farraye FA, Hashash JG
Use of Immune Checkpoint Inhibitors in Patients With Inflammatory Bowel Disease After Ileal Pouch-Anal Anastomosis.
Inflamm Bowel Dis. 2023 Jun 1:izad098. doi: 10.1093.
PubMed

CUSHING KC, Chen Y, Du X, Chen V, et al
Risk Variants in or Near ZBTB40 AND NFATC1 Increase the Risk of Both IBD and Adverse Bone Health Outcomes Highlighting Common Genetic Underpinnings Across Both Diseases.
Inflamm Bowel Dis. 2023;29:938-945.
PubMed Abstract available

SOUSA P, Noor NM
Revisiting Drug Development for Older Molecules in IBD.
Inflamm Bowel Dis. 2023;29:1012-1013.
PubMed

BOUHNIK Y, Atreya R, Casey D, Gorecki M, et al
Cost-effectiveness Analysis of Subcutaneous Infliximab for Inflammatory Bowel Diseases in Sequential Biologic Treatment.
Inflamm Bowel Dis. 2023;29:898-913.
PubMed Abstract available

RIVIERE P, Kanters C, Pellet G, Ni A, et al
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral Centers.
Inflamm Bowel Dis. 2023;29:923-931.
PubMed Abstract available

SHORE BM, Weaver KN, Allegretti JR, Herfarth HH, et al
Prevalence of Clostridioides difficile Infection After Ileal Pouch-anal Anastomosis in Patients With Chronic Antibiotic-dependent Pouchitis and Crohn's-like Disease of the Pouch.
Inflamm Bowel Dis. 2023;29:932-937.
PubMed Abstract available

AXELRAD JE, Li T, Bachour SP, Nakamura TI, et al
Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
Inflamm Bowel Dis. 2023;29:888-897.
PubMed Abstract available

FAN Y, Zhang L, Omidakhsh N, Bohn RL, et al
Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Inflamm Bowel Dis. 2023;29:914-922.
PubMed Abstract available

WONG ECL, Yusuf A, Pokryszka J, Dulai PS, et al
Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn's Disease.
Inflamm Bowel Dis. 2023;29:875-882.
PubMed Abstract available

SEDANO R, Guizzetti L, McDonald C, Beaton M, et al
Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naive Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian Center.
Inflamm Bowel Dis. 2023;29:866-874.
PubMed Abstract available

May 2023

HSU P, Choi EJ, Patel SA, Wong WH, et al
Responsiveness to Vedolizumab Therapy in Ulcerative Colitis is Associated With Alterations in Immune Cell-Cell Communications.
Inflamm Bowel Dis. 2023 May 26:izad084. doi: 10.1093.
PubMed Abstract available

CHAVANNES M, Hart L, Hayati Rezvan P, Dillman JR, et al
Bedside Intestinal Ultrasound Predicts Disease Severity and the Disease Distribution of Pediatric Patients With Inflammatory Bowel Disease: A Pilot Cross-sectional Study.
Inflamm Bowel Dis. 2023 May 25:izad083. doi: 10.1093.
PubMed Abstract available

HSIA K, Zhao N, Chung M, Algarrahi K, et al
Alterations in the Fungal Microbiome in Ulcerative Colitis.
Inflamm Bowel Dis. 2023 May 23:izad082. doi: 10.1093.
PubMed Abstract available

DALAL RS, Sharma PP, Bains K, Pruce JC, et al
1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure.
Inflamm Bowel Dis. 2023 May 20:izad087. doi: 10.1093.
PubMed Abstract available

LOEB L, Nasir A, Picco MF, Hashash JG, et al
Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 May 17:izad088. doi: 10.1093.
PubMed

MA R, Zhu Y, Li X, Hu S, et al
A Novel Serum Metabolomic Panel for the Diagnosis of Crohn's Disease.
Inflamm Bowel Dis. 2023 May 17:izad080. doi: 10.1093.
PubMed Abstract available

KOPYLOV U, Burisch J, Ben-Horin S, Braegger F, et al
Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study.
Inflamm Bowel Dis. 2023 May 9:izad075. doi: 10.1093.
PubMed Abstract available

MCDONALD C, Kerr H, Gibbons E, Lukose T, et al
Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn's Disease: An Experience of 2 IBD Centers.
Inflamm Bowel Dis. 2023 May 9:izad073. doi: 10.1093.
PubMed Abstract available

CHEN X, Elson CO, Dunkin D
Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation.
Inflamm Bowel Dis. 2023;29:798-807.
PubMed Abstract available

LAI HJ, Doan HT, Lin EY, Chiu YL, et al
Histones of Neutrophil Extracellular Traps Directly Disrupt the Permeability and Integrity of the Intestinal Epithelial Barrier.
Inflamm Bowel Dis. 2023;29:783-797.
PubMed Abstract available

CAO H, Diao J, Liu H, Liu S, et al
The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:818-829.
PubMed Abstract available

BEZZIO C, Fiorino G, Ribaldone DG, Armuzzi A, et al
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame.
Inflamm Bowel Dis. 2023;29:834-836.
PubMed

DALAL RS, Pruce JC, Allegretti JR
Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:830-833.
PubMed

HUTFLESS S, Jasper RA, Tilak A, Ghosh T, et al
A Systematic Review of Crohn's Disease Case Definitions in Administrative or Claims Databases.
Inflamm Bowel Dis. 2023;29:705-715.
PubMed Abstract available

CHAN M, Fung M, Chin Koon Siw K, Khanna R, et al
Examination Under Anesthesia May Not Be Universally Required Prior to Anti-TNF Therapy in Perianal Crohn's Disease: A Comparative Cohort Study.
Inflamm Bowel Dis. 2023;29:763-770.
PubMed Abstract available

HOLKO P, Kawalec P, Sajak-Szczerba M, Avedano L, et al
Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries.
Inflamm Bowel Dis. 2023;29:752-762.
PubMed Abstract available

NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.
Inflamm Bowel Dis. 2023;29:716-725.
PubMed Abstract available

April 2023

WONG ECL, Dulai PS, Marshall JK, Jairath V, et al
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index.
Inflamm Bowel Dis. 2023 Apr 28:izad074. doi: 10.1093.
PubMed Abstract available

ZITTAN E, Mahajna H, Salomon N
Attitudes Toward Integrative Medicine in Inflammatory Bowel Disease: A Survey Among Israeli Inflammatory Bowel Disease Experts.
Inflamm Bowel Dis. 2023 Apr 28:izad072. doi: 10.1093.
PubMed

GKIKAS K, Wan M, Svolos V, Nichols B, et al
YouTube as a Source of Information for Food, Diet-Related Items, and Advisory Comments for the Management of Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 26:izad076. doi: 10.1093.
PubMed Abstract available

ATIA O, Magen Rimon R, Ledderman N, Greenfeld S, et al
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.
Inflamm Bowel Dis. 2023 Apr 21:izad057. doi: 10.1093.
PubMed Abstract available

YANG X, Shi J, Wang G, Chen H, et al
Novel mRNA Signature for Anti-TNF-alpha Therapy Primary Response in Patients With Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Apr 20:izad060. doi: 10.1093.
PubMed Abstract available

MCBRIDE RB, Suarez-Farinas M, Ko HM, Chen X, et al
Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Apr 19:izad063. doi: 10.1093.
PubMed Abstract available

YANG Y, Carrero JJ
Reply: Causal Relationship Between Estimated Glomerular Filtration Rate and Inflammatory Bowel Disease: Genetic Evidence From Bidirectional Mendelian Randomization Analysis.
Inflamm Bowel Dis. 2023 Apr 19:izad069. doi: 10.1093.
PubMed

LIU M, Ye Z, Sun Z
Causal Relationship Between Estimated Glomerular Filtration Rate and Inflammatory Bowel Disease: Genetic Evidence From Bidirectional Mendelian Randomization Analysis.
Inflamm Bowel Dis. 2023 Apr 19:izad067. doi: 10.1093.
PubMed

SCHELL TL, Ramirez O, Almasry M, Farraye FA, et al
Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 18:izad068. doi: 10.1093.
PubMed

VASUDEVAN A, Tharayil V, Raffals LH, Bruining DH, et al
Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 18:izad065. doi: 10.1093.
PubMed Abstract available

NOURELDIN M, Newman KL, Higgins PDR, Piette JD, et al
Profiles of Web-based Portal Users with Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Apr 18:izad056. doi: 10.1093.
PubMed Abstract available

DAWWAS GK, Weiss A, Constant BD, Parlett LE, et al
Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases.
Inflamm Bowel Dis. 2023 Apr 12:izad053. doi: 10.1093.
PubMed Abstract available

YERUSHALMY-FELER A, Olbjorn C, Kolho KL, Aloi M, et al
Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
Inflamm Bowel Dis. 2023 Apr 12:izad064. doi: 10.1093.
PubMed Abstract available

KILIC Y, Kamal S, Jaffar F, Sriranganathan D, et al
Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Apr 12:izad061. doi: 10.1093.
PubMed Abstract available

LOLY JP, Vieujean S, Reenaers C, Van Kemseke C, et al
In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab.
Inflamm Bowel Dis. 2023 Apr 12:izad066. doi: 10.1093.
PubMed Abstract available

TSE CS, Weng CH, Kwon M, Wolk CB, et al
Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017.
Inflamm Bowel Dis. 2023 Apr 7:izad062. doi: 10.1093.
PubMed

CHEN D, Tang H, Li Y, Yang H, et al
Vitamin D3 and Lactobacillus rhamnosus GG/p40 Synergize to Protect Mice From Colitis by Promoting Vitamin D Receptor Expression and Epithelial Proliferation.
Inflamm Bowel Dis. 2023;29:620-632.
PubMed Abstract available

ASHTON JJ, Cheng G, Stafford IS, Kellermann M, et al
Prediction of Crohn's Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker.
Inflamm Bowel Dis. 2023;29:511-521.
PubMed Abstract available

NOOR NM, Lee JC
The Endoscopic Healing Index in Crohn's Disease: A Serum Proteomic Biomarker for Monitoring Disease Activity.
Inflamm Bowel Dis. 2023;29:669-671.
PubMed

HOLMER AK, Boland BS, Singh S, Neill J, et al
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's Disease.
Inflamm Bowel Dis. 2023;29:555-562.
PubMed Abstract available

PARK J, Chun J, Yoon H, Cheon JH, et al
Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study.
Inflamm Bowel Dis. 2023;29:548-554.
PubMed Abstract available

RISPO A, de Sire R, Mainenti PP, Imperatore N, et al
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease.
Inflamm Bowel Dis. 2023;29:563-569.
PubMed Abstract available

D'AMICO F, Tasopoulou O, Fiorino G, Zilli A, et al
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.
Inflamm Bowel Dis. 2023;29:539-547.
PubMed Abstract available

VUYYURU SK, Nguyen TM, Hogan M, Raine T, et al
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Apr 1:izad052. doi: 10.1093.
PubMed Abstract available

March 2023

DENG L, He S, Li Y, Ding R, et al
Identification of Lipocalin 2 as a Potential Ferroptosis-related Gene in Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Mar 31:izad050. doi: 10.1093.
PubMed Abstract available

DERKS MEW, van Lierop LMA, Te Groen M, Kuijpers CCHJ, et al
Long-Term Impact of the COVID-19 Pandemic on Inflammatory Bowel Disease Healthcare Utilization: A 2-Year Nationwide Update.
Inflamm Bowel Dis. 2023 Mar 31:izad055. doi: 10.1093.
PubMed

TANDON P, Chhibba T, Natt N, Singh Brar G, et al
Significant Racial and Ethnic Disparities Exist in Health Care Utilization in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2023 Mar 28:izad045. doi: 10.1093.
PubMed Abstract available

AKIYA A, Takahashi K, Akimoto S, Hosono Y, et al
Novel Findings of Early Cardiac Dysfunction in Patients With Childhood-Onset Inflammatory Bowel Disease Using Layer-Specific Strain Analysis.
Inflamm Bowel Dis. 2023 Mar 27:izad031. doi: 10.1093.
PubMed Abstract available

ANYANE-YEBOA A, Buadu MAE, Khalili H, Cozier YC, et al
Epidemiology of Inflammatory Bowel Disease in a Cohort of US Black Women.
Inflamm Bowel Dis. 2023 Mar 22:izad049. doi: 10.1093.
PubMed Abstract available

LU X, Zhou ZY, Xin Y, Wang MJ, et al
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis.
Inflamm Bowel Dis. 2023 Mar 22:izad037. doi: 10.1093.
PubMed Abstract available

KAYAL M, Posner H, Milwidsky HM, Plietz M, et al
Acute Severe Ulcerative Colitis Is Associated With an Increased Risk of Acute Pouchitis.
Inflamm Bowel Dis. 2023 Mar 20:izad039. doi: 10.1093.
PubMed Abstract available

RABINOWITZ LG
Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.
Inflamm Bowel Dis. 2023 Mar 18:izad047. doi: 10.1093.
PubMed

COLLEN LV
Rapid Clinical Remission With Upadacitinib in a Pediatric Patient With Refractory Crohn's Disease.
Inflamm Bowel Dis. 2023 Mar 18:izad048. doi: 10.1093.
PubMed

GOODSALL TM, Day AS, Andrews JM, Ruszkiewicz A, et al
Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study.
Inflamm Bowel Dis. 2023 Mar 16:izad043. doi: 10.1093.
PubMed Abstract available

MARRIE RA, Fisk JD, Dolovich C, Lix LM, et al
Psychometric Performance of Fatigue Scales in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Mar 14:izad038. doi: 10.1093.
PubMed Abstract available

VARMA S, Trudeau SJ, Li J, Freedberg DE, et al
Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series.
Inflamm Bowel Dis. 2023 Mar 14:izad035. doi: 10.1093.
PubMed Abstract available

BUIE MJ, Coward S, Shaheen AA, Holroyd-Leduc J, et al
Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study.
Inflamm Bowel Dis. 2023 Mar 14:izad020. doi: 10.1093.
PubMed Abstract available

AGOSTINI A, Benuzzi F, Ballotta D, Rizzello F, et al
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages.
Inflamm Bowel Dis. 2023 Mar 10:izad029. doi: 10.1093.
PubMed Abstract available

ALMOMEN HS, Al-Bawardy B
Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation.
Inflamm Bowel Dis. 2023 Mar 8:izad040. doi: 10.1093.
PubMed

LIU R, Li Z, Ye L, Hu J, et al
Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn's Disease on Ustekinumab: A Nationwide Real-World Study.
Inflamm Bowel Dis. 2023 Mar 6:izad032. doi: 10.1093.
PubMed Abstract available

KUNISAKI R, Ikeda A, Yaguchi K, Onishi M, et al
To Be in Remission or in Corticosteroid-free Remission: That Is the Question for Women With Inflammatory Bowel Disease at Conception.
Inflamm Bowel Dis. 2023 Mar 6:izad023. doi: 10.1093.
PubMed

MOURAD FH, Maalouf RG, Aoun R, Gustavo Kotze P, et al
Are the New Biologics Effective in the Management of Postoperative Crohn's Disease?
Inflamm Bowel Dis. 2023 Mar 4:izad033. doi: 10.1093.
PubMed Abstract available

SCHROEDER MK, Tan SA, Touma MJ, Basit M, et al
Automated Clinical Pathway Utilizing Custom Risk Stratification Identifies Substantial Rates of Overdue Follow-up Among Patients With Inflammatory Bowel Disease and Facilitates Population Health Interventions.
Inflamm Bowel Dis. 2023 Mar 2:izad026. doi: 10.1093.
PubMed

CHIBA M, Hosoba M, Yamada K
Plant-Based Diet Recommended for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Mar 1:izac279. doi: 10.1093.
PubMed

LIMKETKAI BN
Reply: Plant-Based Diet Recommended for Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2023 Mar 1:izad022. doi: 10.1093.
PubMed

GEERTSEMA S, Otten AT, Bouwknegt DG, Visschedijk MC, et al
Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:e10-e11.
PubMed

MASSELOT CR, Cordier C, Marsac B, Nachury M, et al
Fecal Mucin O-Glycans as Novel Biomarkers in Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2023;29:e12.
PubMed

CHIRRA P, Sharma A, Bera K, Cohn HM, et al
Integrating Radiomics With Clinicoradiological Scoring Can Predict High-Risk Patients Who Need Surgery in Crohn's Disease: A Pilot Study.
Inflamm Bowel Dis. 2023;29:349-358.
PubMed Abstract available

MCKENNA NP, Kelley SR, Bews KA, Behm KT, et al
Surgical Management of Enterovesical Fistula in Crohn's Disease in the Biologic Era.
Inflamm Bowel Dis. 2023;29:480-482.
PubMed

GU P, Dube S, McGovern DPB
Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature.
Inflamm Bowel Dis. 2023;29:458-469.
PubMed Abstract available

SHEHAB M, Alrashed F, Heron V, Restellini S, et al
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Inflamm Bowel Dis. 2023;29:367-375.
PubMed Abstract available

TURSI A, Mocci G, Allegretta L, Aragona G, et al
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Inflamm Bowel Dis. 2023;29:376-383.
PubMed Abstract available

KASSIM G, Yzet C, Nair N, Debebe A, et al
Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.
Inflamm Bowel Dis. 2023;29:417-422.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.